rfhg_32425.1

Basic information about the TSS

---

TSS ID: rfhg_32425.1 Species: human Chr: chr2		Start: 135741718 End: 135741734 Strand: +
Source datasets	PRJNA615891|PRJNA401781|PRJNA548673
Protocol	SLIC_CAGE|TIF-seq2|CAGE|ReCappable-seq
TSS cluster detected*	4

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3182164,EH38E2035164)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000415164.5:0 GeneID: 23190 HGNC/MGI_ID: HGNC:14860 UniProt_ID: C9JLR4 Nearer transcript ids and distances: BC035594:41 ENST00000426921.5:52 EF199840:68 AK311058:-92 BX647662:94 ENST00000272638.14:121 NM_014607.4:121 AK304096:121 BX647216:127 D87684:132 ENST00000416538.5:134 BC020806:134 AK292829:192 KJ902297:196 CU690126:196 AB527369:196 AM392761:196 AM393478:196 DQ894302:196 KJ893338:196 DQ891123:196 AK026971:262 view more...

Gene_name: UBX domain protein 4 Gene_symbol: UBXN4 Gene_synonyms: KIAA0242 Gene_source: HGNC:14860

TATA-Box annotation

---

Distance to TSS:	-129
Nearest PromoterID:	NM_014607
Entrez ID:	23190
Nearest Unigene:	Hs.591242
Nearest Refseq:	NM_014607
Nearest Ensembl:	ENSG00000144224
Gene Name:	UBX domain protein 4
Gene Alias:	UBXD2|UBXDC1|erasin
Gene Type:	protein-coding
CpG%:	0.125000
GC%:	0.647059
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBXN4 p2@UBXN4 p3@UBXN4 p4@UBXN4 p5@UBXN4 p6@UBXN4
Sample		p1@UBXN4	p2@UBXN4	p3@UBXN4	p4@UBXN4	p5@UBXN4	p6@UBXN4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	32.73	6.04	4.48	1.36	0.58	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	33.99	5.26	3.44	1.01	0.61	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	32.41	7.72	5.79	0.96	1.35	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	25.16	4.78	2.70	1.04	0.83	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	26.55	4.95	4.05	0.90	1.35	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	31.20	3.49	3.88	2.91	0.97	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	40.09	8.06	5.45	2.18	1.09	2.18
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	32.70	3.63	6.06	1.70	0.97	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	32.48	6.41	2.99	0.64	0.21	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	44.05	8.69	8.69	1.74	2.32	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	40.02	4.85	6.87	2.83	0.81	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	48.38	6.50	5.29	2.85	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	31.75	8.70	4.03	0.48	0.64	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	34.28	9.17	2.10	0.75	0.75	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	34.03	6.59	4.83	0.44	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	28.67	5.78	2.51	1.26	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	28.39	6.55	1.09	0.44	0.00	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	22.78	3.80	3.80	0.42	1.27	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	22.93	1.60	3.20	0.00	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	30.54	8.73	1.65	1.20	0.30	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	33.95	8.29	2.54	0.80	0.13	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	32.28	5.87	1.38	0.52	0.35	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	30.76	7.63	2.59	0.78	0.13	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	33.25	10.43	1.70	0.73	0.73	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	28.89	6.97	2.32	1.03	0.00	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	25.32	8.23	1.90	1.58	0.63	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	23.63	3.30	3.85	0.55	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	33.24	8.96	2.36	1.41	0.71	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.65	7.27	2.91	0.97	0.65	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	34.75	8.51	1.99	1.27	0.00	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	29.94	4.81	2.09	1.05	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	27.55	8.60	3.13	0.78	0.39	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	31.23	7.17	3.59	0.84	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	46.68	5.77	4.95	1.15	0.66	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	34.41	6.54	2.62	1.50	0.19	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	36.03	8.24	3.45	0.57	0.38	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	39.85	6.54	4.09	0.82	1.02	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.43	6.25	2.42	1.21	0.40	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	36.19	8.10	2.43	1.62	0.54	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	33.37	8.16	4.32	0.24	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	33.17	8.23	4.47	1.65	0.24	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	39.67	7.47	4.54	1.76	0.44	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	37.75	7.59	4.22	0.84	0.63	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	37.06	8.22	4.72	1.57	0.35	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.75	6.42	3.41	0.60	0.80	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	40.95	4.89	1.63	0.93	0.47	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	32.39	7.44	3.60	0.48	1.44	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	42.03	7.45	2.38	1.49	0.30	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	39.98	4.31	3.11	2.63	0.24	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	43.07	6.67	4.04	1.21	0.40	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	49.19	7.79	6.15	0.61	0.82	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	47.59	9.34	3.56	2.00	0.22	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1189.34	111.94	41.98	13.99	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	37.97	3.90	5.68	0.35	0.00	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	36.45	6.96	2.65	0.99	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	111.58	9.23	5.87	3.36	1.68	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	58.32	8.27	4.59	0.92	0.46	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	36.62	7.13	5.19	0.97	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	35.33	6.42	2.89	0.96	0.64	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	57.52	7.23	2.83	2.20	0.63	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	28.20	5.64	0.71	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	29.16	3.93	5.61	0.56	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	69.26	8.76	2.39	0.80	2.39	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	47.23	7.47	4.42	1.02	0.68	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	37.37	9.10	5.20	0.97	0.97	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	23.43	7.45	2.48	1.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	872.85	96.98	32.33	16.16	0.00	48.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	671.29	86.87	31.59	0.00	15.79	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	33.15	2.93	0.49	0.00	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.22	2.48	0.99	0.99	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	39.87	3.75	2.35	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	51.67	3.64	1.32	1.32	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	44.24	3.71	1.55	0.00	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	40.05	3.67	1.53	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	27.08	21.38	9.19	2.06	1.27	0.16
Adipocyte - breast, donor2	11327-117E4	18.61	17.01	4.97	1.28	0.32	0.48
Adipocyte - omental, donor1	11473-119C6	29.39	22.01	8.27	2.16	1.40	0.25
Adipocyte - omental, donor2	11474-119C7	17.19	8.22	3.74	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	22.77	13.06	6.36	1.00	1.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	15.31	12.12	5.74	0.64	2.55	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	5.50	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.00	12.19	3.16	2.26	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	8.69	9.91	4.34	0.87	1.04	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	49.68	23.47	12.52	3.91	0.98	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	36.55	17.76	9.27	1.54	1.80	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	41.54	20.63	7.25	2.79	0.56	1.67
Adipocyte differentiation, day04, donor4	13028-139E4	41.73	23.51	12.93	4.11	2.35	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	51.80	29.76	12.39	2.09	1.53	1.37
Adipocyte differentiation, day08, donor2	13023-139D8	34.53	16.78	7.10	3.23	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	23.99	9.06	4.27	1.60	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	38.39	22.26	16.69	3.90	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	21.21	13.31	6.24	1.25	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	25.62	17.08	8.29	1.00	2.51	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	30.43	18.00	7.85	0.33	0.65	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	24.97	13.40	11.27	0.00	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	5.52	3.31	0.88	0.66	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	3.23	1.08	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	7.92	4.86	2.52	0.00	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.14	3.70	2.26	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	30.55	21.74	8.58	1.72	0.46	0.46
Anulus Pulposus Cell, donor2	11463-119B5	22.29	21.31	4.90	0.98	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	27.41	11.68	4.49	1.35	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	29.09	6.51	7.38	0.87	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	10.70	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	24.21	11.36	5.38	0.90	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	25.29	10.12	8.85	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	7.26	5.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	17.54	5.85	5.85	0.97	0.32	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	27.18	8.74	3.88	1.94	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.00	7.13	2.38	1.19	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	25.61	12.43	3.01	1.13	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.04	8.71	5.81	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	3.76	1.25	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.99	8.40	5.27	0.66	0.66	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	40.94	9.55	5.46	1.36	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.29	8.14	4.07	0.90	0.15	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	21.43	10.72	1.61	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	23.24	11.15	3.40	0.76	0.38	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	18.18	7.75	4.54	0.53	0.80	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	25.36	10.73	7.80	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	23.22	9.95	3.15	0.33	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	6.00	2.40	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	10.62	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	25.73	8.92	4.12	1.20	1.03	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	8.39	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	31.55	12.14	4.37	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	26.18	11.00	6.07	0.76	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	16.96	10.90	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	25.65	11.97	3.99	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	22.87	10.26	3.21	1.28	1.71	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	18.84	4.39	3.10	1.03	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	19.71	12.20	1.88	1.88	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	21.87	10.29	1.93	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	4.99	2.14	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.72	6.43	4.68	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.78	8.73	3.61	1.51	1.20	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	14.26	8.32	3.56	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	20.85	9.66	5.09	1.02	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	23.94	6.88	4.33	0.25	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	16.52	1.91	3.18	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.15	8.20	2.16	1.29	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	18.84	9.53	4.23	0.85	0.64	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.02	4.06	3.19	0.87	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.96	8.50	6.61	0.00	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	21.36	10.68	2.37	1.70	0.68	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	35.91	10.56	12.68	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	21.01	7.93	3.00	0.64	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	15.04	7.22	5.41	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	21.87	8.75	2.92	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	29.88	11.03	5.06	0.92	0.23	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	10.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.05	9.15	4.32	1.02	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	28.70	10.12	4.54	0.62	0.41	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	25.09	6.43	1.84	1.22	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	32.03	8.60	5.26	0.48	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.73	6.87	4.66	0.22	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	3.05	4.58	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	23.82	6.65	4.43	1.66	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	30.45	10.86	2.65	0.53	1.06	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.99	5.09	2.54	0.73	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	9.46	7.25	3.19	0.86	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	7.02	4.28	1.71	0.51	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	3.15	1.89	1.26	0.63	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	48.45	24.40	16.03	2.44	0.70	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	48.21	16.99	8.41	2.26	0.81	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	41.62	21.03	11.19	2.24	1.19	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	62.73	27.41	8.14	2.29	1.15	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	63.89	26.94	6.89	1.75	1.50	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	66.57	24.81	9.45	2.39	1.37	1.37
Basophils, donor1	12241-129G9	13.34	18.31	14.65	4.71	2.09	0.52
Basophils, donor2	12242-129H1	37.88	51.23	22.73	8.30	1.44	0.72
Basophils, donor3	12243-129H2	15.88	38.37	15.43	5.88	2.79	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	1.94	3.88	1.51	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	0.46	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	21.52	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	9.41	6.90	2.51	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	6.45	5.20	1.25	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	11.74	5.07	0.69	0.69	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	19.61	16.20	3.60	0.90	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	43.59	25.25	10.82	4.53	1.75	2.16
Burkitt's lymphoma cell line:RAJI	10476-106I8	48.68	31.21	5.36	1.40	1.16	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.22	40.61	20.47	10.55	2.24	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	72.39	31.03	41.37	20.68	10.34
CD14+ Monocytes, donor1	11224-116B9	16.34	51.85	23.67	7.89	5.64	0.56
CD14+ Monocytes, donor2	11305-117B9	22.83	52.15	25.61	6.50	5.38	0.56
CD14+ Monocytes, donor3	11381-118B4	29.20	58.62	26.78	8.12	6.15	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	29.72	54.91	19.25	3.68	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	42.08	52.31	16.68	6.07	1.14	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	44.38	63.45	17.42	2.96	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	24.14	40.04	12.86	4.48	2.31	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	21.73	30.78	8.75	3.62	1.51	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	26.06	45.01	15.16	4.26	2.84	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	23.60	37.33	13.89	6.36	3.01	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	27.88	28.98	14.63	5.80	2.48	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	35.95	40.91	16.86	8.68	2.23	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	26.63	30.94	16.84	6.85	3.13	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	23.68	32.58	10.68	5.52	3.74	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	36.34	52.88	19.80	7.40	2.83	1.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	23.88	34.88	10.77	4.21	3.51	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	30.63	40.66	19.01	6.34	1.58	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	33.28	48.81	22.19	5.55	7.77	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	23.35	39.42	10.26	4.31	2.97	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	30.73	30.53	9.98	5.19	1.40	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	37.06	44.14	16.66	4.58	2.08	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	23.34	37.29	14.64	5.26	2.97	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.91	33.70	18.55	4.52	2.04	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	30.55	28.37	17.46	6.55	2.62	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.29	39.54	16.95	7.53	2.15	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	30.88	42.39	12.74	5.06	3.66	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	36.19	58.07	18.94	5.47	2.95	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	24.62	41.89	16.90	7.16	3.49	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	30.65	28.89	15.15	11.27	4.23	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	25.45	39.05	25.01	9.65	3.07	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	31.21	36.62	13.95	7.50	3.84	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	26.02	33.82	10.04	7.81	4.09	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	46.56	49.58	24.57	10.99	5.39	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	28.25	38.08	12.69	5.73	3.28	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	30.13	35.23	21.79	7.88	4.17	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	30.16	40.60	19.95	4.87	2.32	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	15.26	42.94	15.91	3.49	1.96	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	16.40	41.58	10.63	2.08	1.85	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	12.35	35.96	12.13	2.17	1.52	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	19.78	63.53	18.06	4.67	2.02	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	18.34	59.38	15.72	4.19	3.67	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	22.97	90.08	24.97	5.35	4.68	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	17.86	39.81	9.95	1.28	1.79	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	14.27	43.47	11.86	3.95	2.42	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	17.48	45.06	13.05	2.53	1.89	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	44.71	56.90	20.32	6.10	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	48.81	42.71	13.56	3.39	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	34.17	39.35	18.64	6.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	60.23	45.84	21.85	3.20	2.67	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	61.65	50.93	15.55	5.36	2.14	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	48.43	53.35	19.65	2.81	3.51	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	42.36	41.57	20.39	3.14	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	58.00	54.05	22.41	3.95	3.95	2.64
CD19+ B Cells, donor1	11544-120B5	93.70	67.40	23.84	6.58	5.75	4.11
CD19+ B Cells, donor2	11624-122B4	73.27	51.51	18.14	2.18	2.90	2.90
CD19+ B Cells, donor3	11705-123B4	73.70	40.39	34.83	4.54	1.51	3.53
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	21.01	73.94	69.50	8.49	5.66	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	12.78	36.75	60.32	5.99	4.39	0.00
CD34+ Progenitors, donor1	11545-120B6	37.15	49.20	20.08	8.03	6.02	2.01
CD34+ Progenitors, donor2	11625-122B5	53.93	58.43	57.30	16.85	7.87	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	46.97	55.99	17.66	6.01	3.01	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	42.62	41.26	17.36	4.51	3.38	1.58
CD4+ T Cells, donor1	11225-116C1	27.14	110.33	66.06	17.50	7.86	0.00
CD4+ T Cells, donor2	11306-117C1	22.05	95.53	45.31	16.53	5.51	0.61
CD4+ T Cells, donor3	11382-118B5	28.97	81.74	35.38	14.03	4.57	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	34.97	57.68	18.38	3.83	2.81	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	28.52	49.64	19.76	2.70	2.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	27.88	48.58	15.24	6.32	3.45	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	31.29	73.01	39.82	15.17	3.79	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	30.20	73.04	40.73	16.86	4.21	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	65.92	46.15	13.18	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	42.05	51.59	14.74	6.50	2.75	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	20.00	35.76	15.08	2.20	1.86	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	20.31	36.92	11.93	3.71	0.81	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	32.28	68.14	24.66	7.62	3.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	33.54	59.75	32.14	9.78	3.49	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	44.00	84.04	38.72	7.04	5.72	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	34.15	56.50	21.08	5.90	4.22	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	25.14	33.66	14.34	3.32	2.08	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	18.71	34.42	12.36	3.34	1.67	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	21.48	80.76	42.15	11.97	3.81	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	32.16	106.65	38.05	11.79	6.43	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	10.76	82.49	39.45	17.93	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	36.53	66.57	21.51	5.56	2.78	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	25.78	53.50	19.50	3.68	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	28.37	49.39	19.96	3.99	2.10	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	24.77	74.83	27.30	8.60	3.54	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	26.00	74.52	34.66	9.53	3.03	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	44.02	106.77	36.17	12.20	5.67	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	43.55	77.20	33.16	7.42	4.45	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	43.39	66.47	24.93	8.31	4.62	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	26.52	62.81	20.94	5.58	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	46.52	86.12	42.92	13.29	6.37	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	47.85	107.24	40.73	11.04	1.96	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	33.88	90.86	47.74	16.94	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	36.53	82.37	31.16	7.52	4.66	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	40.16	74.79	23.54	4.15	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	39.61	82.50	28.48	13.10	6.22	0.98
CD8+ T Cells, donor2	11307-117C2	43.17	77.34	31.91	16.52	6.01	0.75
CD8+ T Cells, donor3	11383-118B6	41.66	86.86	40.40	14.90	3.53	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	30.05	2.52	2.98	0.00	0.00	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	32.35	1.20	1.68	0.24	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.55	1.64	1.64	0.00	0.27	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	40.83	1.20	2.10	0.60	0.00	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	32.88	2.40	1.92	0.24	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	30.70	1.36	1.82	0.45	0.23	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	43.02	3.04	1.74	0.87	0.43	2.82
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	40.01	1.58	2.37	0.00	0.53	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	42.92	2.58	1.17	0.47	0.23	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	39.55	2.72	1.21	0.30	0.00	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	38.35	0.87	2.32	0.87	0.00	2.91
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	39.17	1.60	1.60	0.00	0.00	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	51.22	1.75	0.88	0.88	0.00	3.94
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	58.75	2.28	1.82	0.46	0.46	3.19
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	60.42	3.73	1.49	0.00	0.00	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	36.02	1.44	2.16	0.72	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	36.54	1.44	1.44	1.15	0.00	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	26.40	1.65	1.41	0.00	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	59.26	1.58	2.85	0.00	0.00	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	44.90	1.85	0.00	0.62	0.00	2.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	47.77	2.56	1.28	0.00	0.00	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	55.84	2.68	2.68	0.00	0.00	3.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	47.69	1.58	0.39	0.00	0.00	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	49.92	3.78	2.27	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	97.96	5.62	0.00	1.61	0.00	6.42
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	82.53	6.29	2.10	0.70	0.00	5.60
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	128.22	8.01	6.01	1.00	0.00	6.01
Cardiac Myocyte, donor1	11525-119I4	49.35	34.73	9.14	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	29.65	10.87	1.48	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	27.99	11.26	2.42	1.26	0.42	0.74
Chondrocyte - de diff, donor1	11261-116G1	38.83	19.41	6.59	1.39	0.69	1.39
Chondrocyte - de diff, donor2	11338-117F6	26.65	10.31	6.04	1.42	1.07	1.07
Chondrocyte - de diff, donor3	11410-118E6	33.91	16.16	6.14	0.57	0.68	0.57
Chondrocyte - re diff, donor2	11339-117F7	83.26	23.28	10.74	2.69	0.90	1.79
Chondrocyte - re diff, donor3	11411-118E7	25.88	14.56	3.64	1.62	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	79.53	26.74	10.21	3.21	1.26	2.07
Ciliary Epithelial Cells, donor2	11323-117D9	52.37	12.61	4.49	2.14	0.43	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	58.14	14.16	5.22	1.95	0.35	2.12
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.67	33.75	13.66	2.29	1.83	0.55
Corneal Epithelial Cells, donor1	11526-119I5	4.83	3.07	0.44	0.22	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	6.83	10.24	3.41	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.09	4.86	1.53	0.26	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	64.06	11.39	2.64	0.33	0.66	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	66.55	7.57	2.84	0.00	0.95	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	27.61	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	44.28	6.80	1.84	0.11	0.43	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	27.67	67.30	34.51	9.22	4.10	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	35.25	58.76	35.25	8.49	3.26	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	31.94	85.66	52.27	10.65	5.32	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	23.18	4.50	2.33	0.83	0.33	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	16.43	5.87	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	16.69	4.24	1.70	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	27.13	6.68	3.15	0.79	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	9.60	3.49	0.58	1.45	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	26.59	4.94	2.82	0.94	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	16.83	6.84	2.10	1.23	0.35	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	42.78	8.64	2.66	1.11	0.22	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	53.55	10.65	3.65	2.43	0.30	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	69.63	19.17	3.95	1.97	1.13	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	12.78	7.13	0.59	1.19	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	12.50	5.21	1.04	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	10.92	3.83	1.28	0.71	0.14	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	45.21	14.80	2.00	0.40	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	13.10	3.67	1.05	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	82.00	22.49	7.08	4.97	1.24	1.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	50.40	18.03	6.30	4.78	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	54.84	16.85	4.76	2.69	0.73	0.85
Endothelial Cells - Vein, donor1	11267-116G7	22.75	7.96	0.00	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.07	4.89	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	24.34	4.87	1.57	0.63	0.00	0.31
Eosinophils, donor1	12244-129H3	30.49	91.48	15.25	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	82.51	189.78	196.38	54.46	11.55	3.30
Eosinophils, donor3	12246-129H5	53.50	110.57	185.47	78.47	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	3.42	2.20	1.22	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	4.16	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	35.30	15.60	5.75	0.82	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.90	4.60	1.75	0.33	0.33	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.02	4.88	2.38	0.87	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	31.53	17.10	4.12	1.70	0.97	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	56.36	38.21	12.56	3.55	0.68	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	26.89	13.08	3.16	0.84	0.63	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	49.54	27.14	9.75	3.16	1.05	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	31.23	14.95	5.98	2.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	16.33	5.44	3.18	0.45	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	15.92	2.27	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.56	7.10	2.21	0.32	0.79	0.32
Fibroblast - Cardiac, donor4	11452-119A3	58.20	24.25	11.21	2.73	0.61	0.91
Fibroblast - Cardiac, donor5	11456-119A7	31.35	12.06	8.50	1.52	0.38	0.51
Fibroblast - Cardiac, donor6	11460-119B2	30.77	8.19	5.91	1.36	0.45	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	17.82	7.77	3.22	0.67	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	33.65	11.65	6.04	1.29	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	14.65	1.46	4.39	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	11.76	4.84	2.08	0.46	0.92	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	38.50	20.69	7.46	1.36	0.85	0.51
Fibroblast - Dermal, donor1	11269-116G9	17.37	9.86	1.41	1.64	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	13.68	5.19	3.77	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	27.56	6.29	2.78	0.24	0.36	0.48
Fibroblast - Dermal, donor4	11450-119A1	23.06	15.94	6.56	2.03	0.57	0.11
Fibroblast - Dermal, donor5	11454-119A5	25.30	19.54	7.33	2.27	0.87	0.35
Fibroblast - Dermal, donor6	11458-119A9	27.45	18.68	7.63	1.46	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	39.15	25.40	5.83	1.25	1.25	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	51.35	15.46	6.81	1.57	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	26.09	14.50	7.12	1.58	0.79	0.13
Fibroblast - Gingival, donor3	11394-118C8	44.19	23.01	6.67	1.45	0.77	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	52.98	12.47	9.35	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	29.25	12.16	7.22	2.47	0.88	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	43.50	13.72	10.29	0.94	0.62	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	38.81	12.17	7.03	1.35	0.54	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.94	6.35	5.29	1.76	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	38.75	14.48	9.80	1.17	0.73	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	44.86	12.68	8.73	1.36	0.41	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	36.86	15.25	8.12	1.97	0.77	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	42.85	18.78	12.77	2.20	1.03	0.44
Fibroblast - Lung, donor1	11270-116H1	13.59	2.72	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	50.73	22.38	11.94	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	18.57	5.28	2.11	0.84	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	8.33	2.50	2.50	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	1.40	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.68	0.84	0.28	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	18.27	8.12	2.44	0.41	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	33.36	19.98	7.18	2.91	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	38.68	22.75	12.44	2.88	1.21	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	66.71	32.13	9.79	3.37	0.92	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	38.16	16.41	7.63	1.14	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	24.03	10.26	7.29	1.08	0.27	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	34.33	15.19	8.47	2.67	0.93	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	23.10	11.16	4.09	0.88	0.55	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13.00	6.10	1.42	0.41	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7.35	2.67	0.67	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.40	8.70	2.37	1.19	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	53.38	29.77	15.48	4.37	1.39	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	41.03	19.01	7.46	2.31	0.89	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	56.96	13.01	4.53	1.18	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	35.80	20.16	7.82	2.71	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	63.48	16.95	7.66	1.62	1.08	1.84
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	62.76	29.61	9.62	3.54	1.27	1.27
Fibroblast - skin normal, donor1	11553-120C5	39.21	20.18	4.92	0.98	0.98	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	52.53	27.87	14.84	3.61	2.01	1.00
Fibroblast - skin normal, donor2	11561-120D4	42.70	19.79	7.74	3.11	0.50	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	59.54	28.71	14.51	4.84	1.51	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	50.95	16.24	5.96	1.57	0.66	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	76.59	22.39	9.92	1.88	0.85	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	40.73	30.87	9.52	3.28	1.31	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	42.08	23.86	9.27	2.34	0.64	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	25.81	10.96	4.22	0.67	0.67	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	27.13	10.35	3.14	0.94	0.94	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	376.72	132.96	66.48	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	23.53	40.09	8.72	5.23	1.74	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	28.60	13.18	3.99	1.56	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	48.14	17.96	4.94	1.04	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	33.98	25.30	2.56	1.53	0.26	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	18.37	11.48	5.36	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	15.95	10.21	8.29	1.91	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	19.40	19.11	15.69	3.99	1.14	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	46.88	20.96	9.10	1.38	1.10	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	41.78	13.24	6.85	3.20	0.46	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	23.78	18.82	15.26	5.15	0.99	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	42.82	17.45	6.61	3.97	0.79	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	58.05	16.63	6.20	2.61	0.98	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.00	24.32	14.59	4.42	4.86	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	33.21	23.60	8.90	4.38	1.55	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	37.68	21.43	9.85	5.05	0.74	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	25.25	14.24	9.40	1.61	0.81	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	33.70	13.50	5.33	3.10	0.62	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	34.61	11.90	7.75	4.29	0.97	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	22.36	10.17	6.30	2.85	1.22	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	28.98	9.58	5.93	1.14	1.14	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.74	13.70	7.35	2.99	1.00	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	34.10	15.52	12.24	3.93	1.31	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	34.87	11.52	6.21	0.89	0.89	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	35.77	16.53	6.04	3.02	0.32	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	29.04	16.53	6.93	3.35	0.89	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	34.48	11.49	4.44	1.01	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	43.43	15.27	8.31	1.87	1.02	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	47.97	18.27	7.36	3.19	1.42	2.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	56.61	16.23	6.56	2.29	1.25	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	51.23	15.37	6.83	2.05	0.85	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	46.36	14.05	5.86	2.21	0.55	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	50.08	15.47	7.74	2.66	1.08	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.74	18.78	9.19	3.47	0.82	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	41.88	10.93	5.16	1.44	0.83	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	47.39	15.56	6.92	1.84	1.15	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	36.35	10.51	3.50	1.50	0.00	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	34.83	7.72	3.09	1.54	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	46.61	15.01	7.63	2.58	1.11	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	39.71	12.97	7.13	1.95	0.65	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	39.45	13.15	7.70	2.25	0.00	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	36.58	12.41	5.21	2.08	0.57	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	35.75	6.80	3.32	0.95	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	26.76	8.21	4.87	2.13	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	38.78	11.19	4.91	1.36	0.42	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	32.27	9.66	4.39	1.10	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	31.98	11.22	2.81	1.96	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	32.87	11.67	3.61	2.41	0.37	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	31.02	5.88	3.21	0.53	0.53	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	31.98	8.87	3.21	1.84	0.61	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.51	11.14	2.85	1.42	0.26	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	35.78	11.39	2.71	0.54	1.08	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	41.29	9.95	4.98	2.03	1.11	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	29.17	13.82	4.17	2.41	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	56.53	18.84	10.91	3.97	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	34.17	10.29	5.14	1.85	0.53	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.44	8.47	6.05	2.02	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	78.54	28.97	16.52	4.83	0.76	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	38.62	34.84	21.10	6.17	2.59	2.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	30.97	24.81	13.40	6.32	2.31	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	34.78	26.80	11.87	8.18	2.45	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	10.95	8.45	5.32	1.56	0.63	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	10.45	7.91	5.65	2.26	1.13	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	16.60	15.22	6.92	2.77	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	17.32	7.42	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	28.24	14.31	10.06	4.64	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	14.44	14.44	6.42	6.42	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	24.34	10.43	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	23.11	12.37	11.72	1.63	2.60	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	30.47	21.83	10.30	4.12	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	10.00	10.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	28.52	18.74	7.83	2.24	0.56	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	22.88	19.61	7.84	2.29	1.31	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	32.71	11.74	9.23	2.52	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	29.58	13.68	10.50	2.23	1.27	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	25.81	20.38	7.13	1.70	1.02	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	14.62	14.62	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	32.64	14.89	8.59	4.01	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	16.58	10.66	5.03	1.78	1.18	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	11.86	5.08	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	40.59	16.15	8.70	1.66	0.41	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	36.59	14.04	5.52	3.45	0.46	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	0.00	15.81	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	35.75	11.53	9.99	1.92	1.54	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	39.44	13.04	5.22	1.63	0.98	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	39.46	8.03	7.36	1.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	34.67	22.73	10.02	2.31	2.31	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	45.53	19.17	11.64	2.40	2.40	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	44.73	12.42	12.42	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	31.61	13.68	4.72	1.89	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	36.21	14.48	5.43	1.81	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.90	15.77	8.65	1.02	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	51.05	17.55	6.78	0.80	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	52.79	26.15	9.37	3.45	0.99	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	33.05	9.44	12.98	1.18	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	37.34	15.17	10.50	0.58	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	45.20	15.80	8.78	0.44	0.88	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	37.30	11.02	9.32	2.54	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	34.62	8.95	6.57	2.98	0.60	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	35.91	11.65	8.25	1.46	1.46	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	10.27	4.57	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.14	8.73	3.74	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	5.62	2.25	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	24.10	12.37	4.76	1.59	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	17.55	9.61	6.27	0.42	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	18.80	19.03	7.08	2.67	2.09	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	24.14	21.78	9.28	2.53	1.86	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	21.61	23.21	4.32	1.59	3.87	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	17.82	18.91	5.57	1.20	1.86	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	18.27	23.43	7.74	2.36	2.36	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	18.94	17.22	6.67	2.15	2.37	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.06	20.92	6.97	2.49	1.74	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	15.61	19.39	6.86	1.72	1.72	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	20.18	21.79	5.77	2.88	0.96	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	5.04	1.12	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.33	1.73	0.87	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	7.93	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.29	2.82	1.06	0.00	1.41	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.27	2.18	0.73	0.00	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.73	10.32	2.27	0.35	0.35	0.17
Hepatocyte, donor1	11523-119I2	59.32	82.32	7.26	2.42	3.63	1.21
Hepatocyte, donor2	11603-120I1	63.56	34.47	18.31	3.23	2.15	1.08
Hepatocyte, donor3	11684-122I1	59.51	55.83	15.95	2.45	3.07	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	11.75	58.09	39.81	12.40	5.22	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	75.33	52.43	9.61	5.94	2.27	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	41.71	11.11	2.33	1.51	0.41	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	9.55	3.18	3.18	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	13.84	6.92	2.77	4.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	2.50	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	7.69	7.69	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	11.37	4.87	3.25	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	0.00	5.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	7.26	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	14.56	11.91	9.26	5.29	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	13.30	2.22	3.33	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	5.24	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	11.97	8.82	3.15	2.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	6.19	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	21.97	9.69	6.46	1.94	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	8.05	4.83	3.22	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	36.67	6.52	6.52	1.63	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	20.99	10.50	7.98	0.84	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	39.38	7.23	5.63	2.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	26.78	9.23	3.69	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	20.30	2.83	2.36	1.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	24.49	8.16	5.44	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	41.97	10.76	8.61	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	31.76	7.62	5.08	1.27	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	16.43	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	33.16	8.93	5.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	47.39	10.94	1.82	3.65	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	15.80	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	24.99	13.57	2.86	1.43	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	9.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	17.28	8.33	3.70	2.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	12.29	7.02	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	15.72	9.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	26.42	14.60	7.65	2.78	2.09	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	11.07	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	9.73	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.95	6.10	2.62	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	22.50	13.50	4.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	6.97	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	3.20	6.40	2.13	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	5.54	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	14.25	8.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	10.12	5.52	2.76	1.84	1.84	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	6.05	9.08	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	18.63	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5.29	4.23	2.11	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	15.67	13.79	2.04	1.06	0.90	0.16
Keratinocyte - epidermal, donor2	11349-117G8	4.69	3.51	1.17	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	26.50	21.30	4.64	0.95	0.85	0.09
Keratinocyte - oral, donor1	11251-116E9	47.00	24.41	7.38	1.70	0.68	0.11
Keratocytes, donor1	11527-119I6	11.69	5.16	1.38	0.00	0.69	0.00
Keratocytes, donor2	11607-120I5	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	26.28	12.65	2.57	0.99	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	30.77	6.59	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	42.07	12.94	4.31	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	64.93	27.22	8.07	2.54	0.58	0.81
Lens Epithelial Cells, donor3	11690-122I7	48.13	17.66	5.85	1.51	0.40	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	24.31	6.88	1.66	0.71	0.24	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	14.51	5.58	0.84	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	41.71	9.76	1.73	2.05	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	17.74	1.08	2.15	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.66	2.52	1.26	0.95	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	13.80	4.10	1.08	0.54	0.22	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	24.21	5.34	2.46	1.23	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.34	2.53	0.51	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	16.61	4.36	0.99	0.28	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	27.29	1.58	3.16	0.00	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.78	5.43	2.13	1.16	0.00	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.48	1.85	0.74	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	21.60	5.92	2.09	0.00	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.88	4.05	0.95	1.19	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	12.50	2.06	0.41	0.41	0.41	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	28.64	6.16	1.54	1.54	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.42	2.49	0.00	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	13.36	3.48	0.91	1.10	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	28.63	6.58	0.66	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.91	4.10	0.88	0.88	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.96	1.49	1.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	28.13	6.79	0.97	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	18.31	2.96	0.54	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	18.62	4.54	1.06	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.92	3.63	2.07	0.00	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	23.66	5.23	1.26	2.09	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	13.23	4.36	0.75	0.90	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	18.57	4.13	2.75	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.93	3.95	0.38	0.56	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.97	2.33	0.32	0.74	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	31.98	2.42	0.97	0.97	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.92	1.98	0.66	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.28	2.97	1.12	0.50	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	43.68	5.55	1.11	1.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	18.78	2.22	1.73	0.74	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.80	2.06	0.69	0.41	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	24.77	7.40	1.61	2.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	19.78	6.39	1.52	1.22	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	28.55	5.18	0.84	0.14	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.16	4.98	0.71	0.71	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	2.42	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.78	1.09	0.47	0.16	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.92	5.73	1.07	0.36	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	14.70	3.59	1.31	0.65	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.41	2.12	0.71	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	24.26	5.82	2.35	0.87	0.25	1.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.43	1.54	0.77	0.26	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.04	1.49	1.79	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	6.80	6.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	12.27	6.14	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.88	8.16	4.45	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.42	7.62	6.77	0.42	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	3.52	5.63	1.41	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	5.60	3.74	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	5.67	3.09	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	3.57	3.57	2.38	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.25	5.88	4.52	0.90	1.13	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	18.32	15.41	7.56	1.16	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.96	13.96	7.20	1.35	1.80	3.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	13.01	8.13	4.06	1.63	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6.68	6.68	5.14	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	20.82	13.06	8.47	2.82	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	22.65	9.33	3.33	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.75	7.64	4.08	2.55	0.51	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	25.08	15.47	6.94	0.53	1.07	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	27.77	13.98	6.80	2.46	1.70	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.88	8.59	4.29	0.61	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	17.94	7.34	5.71	1.63	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	22.49	12.70	7.71	1.87	1.46	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.62	12.05	8.13	2.80	0.84	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	8.24	6.18	5.15	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.64	12.48	6.68	0.87	1.74	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.04	9.57	6.88	1.49	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	26.56	9.41	7.19	1.11	1.66	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.61	7.42	5.30	1.41	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.55	9.96	4.06	2.21	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	16.12	5.76	3.45	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	15.35	11.13	5.37	1.92	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	13.59	2.83	1.13	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	4.10	4.92	2.46	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.30	5.42	2.71	1.36	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.08	10.77	6.46	1.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	28.38	8.96	5.23	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	15.98	6.32	3.72	1.49	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	17.23	9.48	8.18	0.86	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.98	7.71	2.57	1.71	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	19.32	8.66	4.66	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	7.24	7.84	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.93	6.40	6.40	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	17.87	9.97	3.78	0.34	0.69	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	13.96	7.51	4.29	1.07	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	13.47	2.69	4.71	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.52	8.89	5.93	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	4.65	6.98	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	6.35	4.23	2.12	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.81	10.80	5.60	1.20	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.81	5.09	5.09	0.73	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	11.50	6.90	6.13	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	9.87	6.41	3.95	0.99	2.47	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	1.88	4.70	0.94	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.05	8.55	6.03	2.01	1.51	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.52	8.11	5.86	0.90	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	0.00	8.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.03	9.35	4.01	0.45	1.34	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.95	5.08	5.87	1.56	0.78	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.81	9.24	8.58	0.66	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	24.39	11.94	3.63	2.08	1.56	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	14.88	10.06	6.13	2.63	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	21.80	8.95	4.47	3.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	20.32	7.07	5.30	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	20.83	8.49	4.24	1.54	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.67	6.58	3.04	0.00	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	23.55	9.61	3.84	0.96	0.48	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.47	9.94	1.59	1.99	0.40	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	15.80	6.68	6.68	1.22	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.22	7.61	4.84	2.77	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	17.48	5.70	5.32	0.76	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	21.69	8.26	3.10	1.03	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.91	7.86	1.81	1.81	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.53	6.34	4.44	1.90	0.32	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.79	2.67	4.26	1.07	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	3.45	2.87	2.30	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	13.37	3.60	3.09	1.03	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	11.32	7.07	4.24	2.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	4.54	3.40	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	15.39	4.99	4.99	0.42	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.18	5.48	3.13	3.13	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.12	7.52	5.43	1.25	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	11.62	3.72	1.39	1.86	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.06	6.69	3.35	4.01	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	15.50	4.28	5.88	2.14	0.53	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.38	3.23	3.64	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.01	3.67	5.51	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14.23	7.11	6.22	0.00	2.67	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	15.39	6.84	6.84	3.42	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	10.74	3.83	1.53	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	13.68	3.28	2.74	1.09	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	13.36	4.45	2.23	0.00	1.78	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	17.68	5.20	4.68	1.04	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	5.97	3.98	0.66	1.99	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	4.16	6.24	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	21.88	41.71	8.20	1.82	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	53.40	6.61	4.22	0.37	0.55	1.10
Macrophage - monocyte derived, donor3	11389-118C3	31.07	20.45	6.95	2.36	0.92	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	17.52	14.87	1.06	1.59	1.06	0.53
Mallassez-derived cells, donor2	11929-125I3	64.17	27.57	5.23	1.58	1.11	1.11
Mallassez-derived cells, donor3	11930-125I4	52.68	18.35	4.03	0.97	1.11	1.25
Mammary Epithelial Cell, donor1	11273-116H4	51.52	17.74	4.68	1.00	0.80	0.90
Mammary Epithelial Cell, donor2	11350-117G9	37.64	18.24	3.47	2.03	1.16	1.16
Mammary Epithelial Cell, donor3	11422-118F9	5.74	5.49	1.00	0.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	462.35	54.91	54.23	22.37	4.07	12.88
Mast cell, donor1	11563-120D6	57.53	25.74	18.60	3.68	1.51	0.97
Mast cell, donor2	11565-120D8	70.43	42.50	38.04	7.43	3.86	1.78
Mast cell, donor3	11566-120D9	92.30	64.16	38.50	9.68	4.28	1.58
Mast cell, donor4	11567-120E1	54.25	40.24	53.01	8.33	3.37	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	81.84	14.31	7.87	1.33	0.44	1.22
Mast cell, expanded and stimulated, donor8	11942-126A7	84.63	2.33	3.50	1.75	1.17	2.33
Mast cell, expanded, donor5	11939-126A4	40.73	22.03	10.67	2.18	1.61	0.23
Mast cell, expanded, donor8	11941-126A6	52.89	21.09	20.08	1.67	1.17	0.67
Melanocyte - dark, donor1	11502-119F8	36.32	17.61	4.78	2.39	0.80	0.30
Melanocyte - dark, donor2	11582-120F7	27.69	5.54	2.77	1.38	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	33.25	17.17	8.11	2.61	0.80	0.36
Melanocyte - light, donor1	11274-116H5	8.93	3.06	4.00	0.24	0.24	0.00
Melanocyte - light, donor2	11351-117H1	7.51	2.05	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	2.60	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	19.68	9.89	5.83	1.04	0.52	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	26.89	7.80	4.30	1.34	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	31.34	10.45	6.16	0.80	0.54	0.00
Meningeal Cells, donor1	11493-119E8	18.86	7.82	2.85	0.62	0.12	0.00
Meningeal Cells, donor2	11573-120E7	25.97	6.16	3.08	0.44	0.44	0.44
Meningeal Cells, donor3	11654-122E7	44.74	13.12	6.11	1.63	0.57	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	36.21	11.98	6.84	1.43	0.57	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	47.20	12.28	3.92	1.61	1.01	1.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	0.00	3.92	2.62	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	31.57	12.20	3.59	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	47.01	15.88	6.99	1.69	1.27	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	29.66	11.06	5.03	0.50	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.25	4.18	2.20	0.66	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	3.65	0.73	0.00	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.32	3.27	1.84	0.20	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	33.10	20.50	9.56	1.80	0.28	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.29	2.97	2.60	0.00	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	45.52	18.16	6.84	1.45	1.18	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	19.88	3.26	1.78	0.00	0.89	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.25	3.84	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	43.60	12.41	4.61	0.71	0.35	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	49.41	20.01	3.75	1.25	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.87	12.34	5.81	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	33.15	16.44	5.04	1.86	1.33	0.53
Mesothelial Cells, donor2	12156-128G5	29.53	12.01	3.00	1.50	0.50	1.50
Mesothelial Cells, donor3	11402-118D7	34.54	14.53	5.64	1.08	0.72	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	41.86	17.55	4.05	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	44.58	10.84	8.37	2.22	0.99	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	44.76	7.36	4.12	0.29	0.00	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	65.68	13.83	10.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	45.25	12.40	3.41	0.62	0.93	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	33.60	5.60	2.70	0.21	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	48.64	23.16	13.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	46.80	13.76	3.75	1.25	0.75	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	51.67	7.45	5.12	0.00	0.00	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	136.26	58.40	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	36.38	8.94	4.06	0.61	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	38.41	6.73	3.17	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	17.10	8.55	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	8.85	3.54	0.00	0.00	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.39	7.60	2.66	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	47.37	22.37	3.95	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	27.59	11.67	5.31	0.85	0.64	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	33.15	3.68	2.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	27.72	8.64	6.56	0.60	0.30	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	35.21	10.06	3.35	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	27.85	6.27	6.77	1.51	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	37.08	4.04	3.80	0.00	0.00	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	42.02	13.27	9.95	2.76	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	37.30	10.13	5.99	0.00	0.00	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	33.23	3.58	3.37	0.63	0.00	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	32.41	5.91	3.67	1.22	1.02	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	31.75	6.22	4.08	1.07	0.43	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	37.79	4.89	4.00	0.22	0.22	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	10.32	20.64	10.32	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	27.82	4.82	3.07	1.10	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	44.61	8.11	4.56	0.00	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	46.40	8.28	8.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	34.52	6.52	5.16	1.63	0.27	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	35.88	4.12	5.00	0.88	0.29	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	46.88	7.63	5.45	2.18	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	26.43	2.88	4.32	1.44	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	47.23	2.80	4.40	1.20	0.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	58.96	2.74	13.71	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	30.54	8.01	6.01	1.00	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	42.81	4.08	2.04	2.04	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	35.91	6.13	6.13	0.44	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	54.08	11.04	4.41	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	50.59	8.33	1.28	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	45.62	6.20	4.46	1.24	0.74	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	43.15	9.74	5.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	70.72	13.26	6.63	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	35.56	6.84	5.13	1.37	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	50.76	3.06	3.94	0.44	1.31	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	50.78	8.52	3.55	1.07	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	34.79	4.49	2.24	1.12	0.56	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	46.13	5.40	3.74	1.25	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	50.12	11.07	3.50	1.17	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	37.10	8.45	4.22	1.51	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	51.76	5.43	3.34	0.00	0.00	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	86.63	43.31	28.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	36.94	8.31	6.46	0.00	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	56.34	9.68	7.40	1.14	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	42.01	14.37	2.63	1.52	0.55	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	30.84	7.26	3.63	1.30	0.78	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	68.21	7.72	6.01	1.29	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	49.54	19.06	6.99	0.00	2.54	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	40.83	9.87	3.20	1.07	0.80	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	64.36	14.07	8.98	1.20	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	39.97	13.70	3.81	1.13	0.42	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	30.58	10.83	3.82	1.91	1.27	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	79.61	11.28	3.98	1.77	0.44	1.77
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	50.81	17.44	5.69	1.90	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	42.90	15.91	7.67	1.42	0.57	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	59.73	12.29	7.13	0.74	0.98	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	50.83	18.25	7.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	42.34	17.64	4.12	1.76	1.47	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	63.14	14.42	7.78	2.31	0.86	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	55.23	21.02	8.24	1.65	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	46.16	20.25	6.55	0.89	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	15.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	8.91	7.13	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	23.00	20.04	7.23	0.66	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	8.42	3.16	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	21.94	15.02	6.92	0.99	0.79	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	7.45	3.73	2.79	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	22.91	14.27	6.38	1.13	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	26.63	7.99	4.26	0.80	0.00	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	22.17	21.26	7.35	1.58	0.90	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.73	5.89	2.21	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.92	16.12	5.50	1.47	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	23.33	10.89	14.00	0.00	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	30.46	26.72	6.41	3.21	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	9.09	3.03	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	23.61	8.43	3.79	1.26	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	19.07	6.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.08	3.18	3.18	0.64	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	13.77	20.25	1.62	2.43	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	10.57	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	22.84	11.42	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	3.26	0.00	6.52	3.26	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	188.24	12.55	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	38.35	17.45	3.45	2.15	1.08	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	24.04	20.90	3.66	1.05	0.00	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	9.34	4.00	2.67	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.28	4.17	2.50	0.83	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	30.42	8.94	3.99	1.52	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	47.88	28.73	7.98	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.84	4.08	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	73.51	20.21	11.03	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.14	5.86	5.86	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.50	6.74	3.95	1.86	0.23	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	15.40	7.03	1.35	0.27	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	33.64	14.72	7.78	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	300.64	77.94	44.54	0.00	0.00	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.88	6.95	4.47	0.50	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	22.74	5.95	3.52	1.62	0.00	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	19.49	7.48	1.59	0.91	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	21.07	4.90	2.78	0.65	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	35.18	10.21	5.10	1.64	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	19.10	5.30	3.71	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.81	6.00	2.40	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	31.18	5.91	2.30	0.98	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.91	7.81	3.42	0.49	0.00	1.14
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	39.51	12.17	4.76	1.59	0.71	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	4.22	6.33	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.09	5.98	5.98	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	22.82	6.43	3.53	0.96	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	32.07	6.21	5.86	1.38	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	80.91	20.23	5.06	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	41.66	15.37	7.13	1.56	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.36	4.66	5.08	1.69	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.56	5.70	4.75	0.47	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	17.60	8.16	4.29	0.86	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	379.17	54.17	9.03	18.06	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	18.99	6.00	3.33	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	30.21	16.23	4.06	0.45	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.87	3.97	3.17	0.40	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	16.72	5.57	3.71	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	31.03	9.84	3.03	0.00	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.16	5.87	3.58	0.65	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.05	6.97	5.23	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	40.71	13.57	5.43	2.26	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	1.76	3.53	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.28	5.98	2.66	1.99	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	19.84	3.47	1.98	0.99	0.50	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	24.50	6.89	2.68	2.68	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	34.48	15.73	8.47	2.72	0.60	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	38.90	11.05	2.87	0.66	0.22	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	21.01	5.42	2.03	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	71.53	10.22	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	24.39	7.32	2.44	1.22	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.29	4.72	3.78	0.63	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	17.86	5.45	5.45	2.42	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	17.41	7.12	0.79	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	43.08	6.80	3.40	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	96.10	10.12	20.23	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	36.77	17.39	4.60	1.74	0.37	0.99
Myoblast, donor2	11322-117D8	39.70	15.73	5.37	1.92	0.19	0.19
Myoblast, donor3	11398-118D3	31.11	22.70	7.23	1.85	0.17	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	30.21	31.23	15.76	4.09	1.31	0.29
Natural Killer Cells, donor1	11230-116C6	50.43	73.19	25.22	8.00	4.92	1.54
Natural Killer Cells, donor2	11311-117C6	42.22	61.52	23.52	10.86	3.32	1.21
Natural Killer Cells, donor3	11387-118C1	45.28	57.06	25.77	8.28	3.68	1.29
Neural stem cells, donor1	11275-116H6	86.02	30.12	14.88	5.08	1.09	3.63
Neural stem cells, donor2	11352-117H2	78.95	38.51	38.51	3.85	5.78	1.93
Neurons, donor1	11494-119E9	43.24	18.21	19.34	7.97	1.14	0.00
Neurons, donor2	11574-120E8	24.00	25.54	17.83	3.74	1.76	0.22
Neurons, donor3	11655-122E8	25.49	12.33	22.20	3.29	0.82	0.00
Neutrophils, donor1	11233-116C9	26.91	61.25	77.02	17.63	2.78	0.93
Neutrophils, donor2	11314-117C9	49.28	55.08	49.28	20.29	0.00	2.90
Neutrophils, donor3	11390-118C4	54.36	113.62	100.18	32.99	7.33	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	44.17	25.77	12.11	1.90	0.95	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	20.84	9.12	2.28	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	20.46	11.43	5.21	3.21	0.60	0.80
Olfactory epithelial cells, donor1	11933-125I7	24.64	7.57	3.03	0.69	0.41	0.28
Olfactory epithelial cells, donor2	11934-125I8	33.44	11.29	3.91	1.30	0.43	0.72
Olfactory epithelial cells, donor3	11935-125I9	19.07	9.53	5.68	0.91	0.23	0.45
Olfactory epithelial cells, donor4	11936-126A1	40.52	11.20	4.48	0.58	0.58	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	57.77	17.45	6.02	0.60	1.20	2.41
Osteoblast - differentiated, donor1	11276-116H7	13.40	9.78	4.04	2.55	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	10.29	4.57	3.43	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.93	5.59	3.10	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	5.47	2.35	1.17	0.78	0.00	0.20
Osteoblast, donor2	11354-117H4	34.41	14.05	11.94	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	23.82	9.95	2.49	1.07	0.53	0.71
Pancreatic stromal cells, donor1	11249-116E7	46.25	16.51	7.16	1.60	1.10	0.42
Pericytes, donor1	11491-119E6	3.89	2.78	0.45	0.33	0.11	0.00
Pericytes, donor2	11571-120E5	4.30	3.17	1.81	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	5.49	1.42	0.81	0.41	0.20	0.20
Perineurial Cells, donor1	11499-119F5	50.07	22.72	5.31	1.24	0.79	0.68
Perineurial Cells, donor2	11579-120F4	47.29	11.78	5.61	2.12	0.64	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	32.83	84.15	30.92	10.20	5.10	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	20.57	47.75	17.63	7.59	3.18	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	27.05	54.10	19.41	7.64	3.36	0.00
Placental Epithelial Cells, donor1	11278-116H9	4.78	4.78	4.54	0.96	0.48	0.24
Placental Epithelial Cells, donor2	11355-117H5	12.20	1.11	3.33	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.03	4.32	3.93	0.20	0.00	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	15.51	7.59	2.53	0.95	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	25.51	15.38	6.57	1.13	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	49.86	29.37	13.71	3.00	1.31	0.78
Preadipocyte - breast, donor2	11328-117E5	23.42	16.89	6.53	0.68	0.90	0.23
Preadipocyte - omental, donor1	11468-119C1	35.59	20.57	7.67	1.28	1.07	0.85
Preadipocyte - omental, donor2	11329-117E6	40.59	14.84	8.73	3.06	1.75	0.87
Preadipocyte - omental, donor3	11403-118D8	30.08	14.61	3.72	0.86	0.57	0.29
Preadipocyte - perirenal, donor1	11469-119C2	4.92	11.81	3.94	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	13.21	3.07	1.54	0.31	0.00	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	44.80	6.02	4.78	0.89	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	42.57	5.45	2.55	0.68	0.34	0.85
Preadipocyte - visceral, donor1	11280-116I2	50.39	14.62	6.15	1.58	0.84	0.75
Preadipocyte - visceral, donor2	11357-117H7	46.02	6.90	5.52	1.84	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	27.90	8.46	5.43	0.73	0.31	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	43.75	30.02	7.54	3.47	2.56	2.41
Prostate Epithelial Cells, donor2	11331-117E8	21.80	13.81	2.30	1.62	1.22	0.14
Prostate Epithelial Cells, donor3	11404-118D9	11.70	15.80	6.12	2.27	1.04	0.00
Prostate Stromal Cells, donor1	11254-116F3	31.44	14.92	4.44	1.94	0.80	0.46
Prostate Stromal Cells, donor2	11332-117E9	38.55	8.07	5.20	1.97	0.90	0.54
Prostate Stromal Cells, donor3	11405-118E1	30.03	11.78	5.74	0.63	0.21	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.85	4.38	0.73	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	42.07	14.90	4.92	1.80	0.49	0.35
Renal Epithelial Cells, donor1	11517-119H5	4.57	4.06	3.04	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.27	0.00	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	51.77	18.63	5.08	1.59	0.95	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	5.45	1.36	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.30	4.31	0.54	0.13	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	37.30	11.99	3.11	1.33	0.22	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	0.67	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.80	1.98	0.88	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	8.78	3.76	2.51	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.88	0.83	0.83	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.27	6.17	2.68	0.54	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.86	1.27	0.84	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.91	3.28	0.19	0.39	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	34.74	14.78	7.52	2.33	1.81	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.95	6.82	3.13	0.85	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	2.06	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	39.64	16.31	12.04	2.76	1.51	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	43.57	50.11	26.06	6.68	2.00	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	39.31	18.76	5.36	2.68	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	39.08	12.66	3.85	0.55	2.20	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	78.31	30.16	6.96	1.74	1.16	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	63.84	27.57	2.99	1.69	1.17	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	37.93	16.88	4.37	1.49	0.99	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	51.64	23.65	5.02	2.57	1.34	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	64.13	31.38	5.83	1.98	1.36	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	33.68	15.15	3.15	1.40	1.05	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	37.21	20.57	5.08	1.62	1.16	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	36.97	19.99	5.07	1.78	1.64	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	35.25	16.94	2.72	2.87	1.36	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	32.25	19.53	3.05	2.51	1.43	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	31.56	21.81	4.59	1.72	1.58	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	33.27	17.06	2.90	1.07	0.75	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	32.53	17.48	3.32	1.33	0.89	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	36.32	18.16	2.49	2.10	2.29	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	38.76	15.28	3.07	1.58	1.21	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	50.92	23.68	6.39	2.07	1.50	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	40.08	24.02	4.38	1.06	1.46	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	41.37	19.47	3.50	1.46	1.46	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	36.66	16.80	4.20	2.29	2.10	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	37.70	23.07	3.52	2.78	0.96	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	34.76	15.98	6.17	1.96	0.84	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	36.06	22.56	3.08	1.54	1.20	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	38.84	19.33	5.65	1.28	1.82	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	30.66	17.90	3.07	1.96	1.35	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	44.06	22.97	5.10	1.61	2.15	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	37.98	18.40	4.95	1.65	2.59	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	31.75	16.67	3.37	1.19	1.39	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	38.58	21.98	2.81	3.27	1.17	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	38.78	21.77	5.39	1.66	2.90	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	36.94	15.93	3.54	1.55	0.88	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	37.81	25.48	3.13	1.88	1.04	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	48.45	24.23	5.11	2.02	1.08	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	43.08	16.35	3.75	2.55	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	40.87	23.33	3.47	1.93	0.58	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	43.16	20.46	3.61	1.55	1.38	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	43.76	24.42	3.43	1.23	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	50.89	23.15	5.09	1.97	1.15	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	39.37	19.26	3.24	2.05	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	48.53	22.93	4.14	1.78	0.44	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	43.98	19.19	3.47	2.93	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	47.43	19.22	3.18	2.07	1.11	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	40.24	20.24	5.71	1.43	0.95	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	49.58	27.61	6.45	2.82	1.21	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	38.71	19.49	5.65	1.22	1.04	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.59	11.88	4.54	1.75	0.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	37.17	18.13	2.12	1.21	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	37.94	15.79	3.67	1.84	0.24	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	96.36	37.99	11.79	3.20	2.04	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	37.11	20.08	7.91	1.83	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	33.46	15.67	3.92	1.21	0.60	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	36.87	17.42	4.07	2.26	0.68	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	46.43	17.37	7.19	1.80	1.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	49.24	21.84	4.60	1.53	0.83	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	33.94	20.06	2.99	1.49	2.13	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	49.88	21.64	3.61	1.80	2.40	1.20
Schwann Cells, donor1	11498-119F4	7.33	3.95	1.69	0.38	0.19	0.00
Schwann Cells, donor2	11578-120F3	17.01	6.80	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	18.84	9.64	4.82	1.31	0.44	0.88
Sebocyte, donor1	11220-116B5	18.62	13.69	0.55	1.64	1.10	0.00
Sebocyte, donor2	11301-117B5	5.97	4.60	2.30	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	4.95	5.98	2.47	0.82	0.00	0.00
Sertoli Cells, donor1	11255-116F4	46.38	16.57	3.31	0.00	3.31	1.66
Sertoli Cells, donor2	11333-117F1	25.42	11.30	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	18.83	10.82	5.01	1.50	0.44	0.18
Skeletal Muscle Cells, donor2	11358-117H8	7.23	3.61	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	18.39	5.02	5.85	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	28.12	7.23	4.71	2.04	0.31	0.63
Skeletal Muscle Cells, donor5	11455-119A6	28.24	9.51	5.80	1.34	0.74	0.15
Skeletal Muscle Cells, donor6	11459-119B1	29.55	11.85	3.08	1.39	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	37.68	23.19	11.34	1.13	0.76	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	21.97	17.84	10.27	2.28	0.86	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	30.76	11.61	12.30	1.69	0.60	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	25.44	10.62	4.63	1.35	0.59	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	9.41	5.07	2.17	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.24	2.61	0.55	0.28	0.14	0.28
Skin - palm, donor1	10286-104F7	80.58	142.36	8.06	8.06	8.06	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.08	4.90	1.44	0.58	0.14	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	85.88	22.90	17.18	4.09	0.82	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.72	4.02	0.91	0.39	0.26	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	47.54	19.60	3.61	0.83	0.70	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	32.49	13.08	1.83	0.28	0.14	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	103.40	33.20	10.78	3.38	0.85	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	37.78	18.14	3.07	0.67	1.20	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.57	5.25	1.85	0.62	0.62	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	52.03	32.24	7.34	2.22	1.11	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.99	11.76	2.94	1.18	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.02	5.08	0.66	1.10	0.44	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	8.27	2.76	2.36	0.00	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.04	10.82	3.09	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	24.02	6.00	4.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	16.90	9.05	2.40	0.40	0.13	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	33.47	8.64	3.32	0.89	0.00	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.13	14.60	4.23	0.90	0.51	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	40.70	14.33	9.77	1.63	0.65	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	33.08	20.38	6.79	2.36	0.59	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	29.18	9.82	5.13	0.43	0.71	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.11	1.46	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	25.88	13.09	10.66	1.83	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.94	5.81	2.78	1.01	0.25	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.97	3.81	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	31.56	13.27	6.34	0.74	1.03	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	26.26	10.98	7.32	1.08	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	24.04	12.18	10.71	1.47	0.52	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.96	4.64	1.08	0.46	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	5.39	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.06	4.18	1.49	0.30	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.10	1.37	1.02	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	44.05	17.75	5.42	1.73	0.63	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	26.77	18.12	5.33	1.81	1.31	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	42.55	9.33	5.46	1.59	0.23	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.66	5.43	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	49.01	22.78	7.68	2.65	1.06	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	57.26	18.24	6.92	1.46	0.40	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	31.05	15.28	3.88	2.00	0.38	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	28.16	10.15	7.61	1.78	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.19	11.76	3.92	1.06	0.45	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.75	3.75	1.50	0.00	0.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	34.89	3.88	0.00	0.00	1.29	7.75
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	17.67	7.91	1.86	0.93	0.00	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	18.68	8.58	1.51	0.50	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	23.19	10.97	2.51	0.31	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.47	0.88	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	46.74	19.83	9.75	2.50	1.50	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	26.16	8.88	5.61	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.22	6.19	2.01	0.86	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.49	4.59	2.55	1.02	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.71	3.20	1.50	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	43.60	21.38	7.83	2.10	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	60.41	12.74	2.43	0.92	0.50	4.11
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	0.95	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.21	6.12	0.98	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	49.49	7.73	3.09	1.33	0.44	2.21
Smooth Muscle Cells - Uterine, donor3	11466-119B8	35.40	7.90	2.63	2.34	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	29.15	11.66	7.58	2.53	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	19.57	9.78	1.85	0.53	1.32	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	29.76	7.07	8.55	1.86	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	22.28	15.81	7.19	1.44	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	13.63	12.21	4.54	1.99	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	21.66	7.09	4.73	2.76	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	30.22	12.19	4.32	1.27	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	23.96	10.78	6.79	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	22.99	8.78	5.02	0.84	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	24.75	11.92	5.50	2.75	0.00	0.46
Synoviocyte, donor1	11291-117A4	32.99	10.77	5.39	0.67	0.17	0.84
Synoviocyte, donor2	11368-117I9	35.54	11.23	6.87	1.17	0.50	0.50
Synoviocyte, donor3	11440-118H9	25.02	18.10	5.59	1.79	0.45	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	7.86	4.65	0.36	0.36	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.80	3.94	1.62	0.23	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	14.27	11.18	2.72	0.72	0.22	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	6.57	6.57	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	8.02	4.01	0.57	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	40.35	50.69	27.56	6.64	1.23	0.37
Urethra, donor2	10319-105A4	86.32	39.57	25.18	1.80	3.60	0.00
Urothelial Cells, donor1	11520-119H8	2.66	2.13	0.53	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	6.41	2.40	0.80	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.58	2.52	0.92	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	48.37	16.05	3.34	1.34	0.67	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	20.47	59.62	51.61	13.35	2.67	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	17.16	47.18	45.75	8.58	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.74	33.54	19.85	4.11	2.74	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	16.87	40.63	25.83	9.64	2.75	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	16.27	41.83	21.50	9.30	3.49	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	14.58	59.35	55.19	9.37	3.12	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.03	69.75	52.31	11.01	7.34	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	12.78	33.78	21.91	7.30	5.48	0.00
Wilms' tumor cell line:G-401	10809-111A8	37.38	16.78	8.27	2.71	0.86	0.99
Wilms' tumor cell line:HFWT	10597-108E3	31.68	14.96	4.40	0.88	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	25.42	27.93	5.87	3.91	1.96	0.28
achilles tendon, donor2	10292-104G4	43.40	26.86	6.20	2.07	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	33.65	30.59	12.75	2.80	0.76	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	43.88	45.27	8.82	3.02	3.25	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	74.43	51.16	21.37	6.65	1.78	2.14
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	22.59	59.05	22.59	6.26	1.90	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	21.92	21.08	8.15	2.81	1.69	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	32.78	33.41	11.00	4.86	2.11	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	25.86	38.11	10.07	6.26	2.18	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	42.74	41.86	10.58	5.29	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	20.83	34.30	7.76	4.90	3.27	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	40.77	40.38	10.48	3.88	2.33	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	15.46	24.47	3.50	2.39	2.02	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	140.42	128.72	27.30	11.70	7.80	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	38.58	23.70	7.90	3.95	2.09	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	24.08	36.76	7.51	5.18	2.33	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	23.67	42.38	7.89	1.17	1.17	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	18.13	39.04	16.27	2.32	1.86	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	28.38	31.26	6.17	2.06	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	14.12	14.43	2.76	0.61	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	22.19	28.16	5.55	1.28	1.28	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	22.14	26.99	7.28	1.52	1.21	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	31.05	31.53	5.05	1.93	2.65	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	11.81	30.52	10.25	3.34	2.00	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	45.03	22.68	14.01	5.00	2.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	31.59	9.29	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	25.24	18.83	13.94	2.64	2.26	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	35.76	40.56	15.26	3.49	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	56.23	52.48	9.37	11.25	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	53.93	35.32	6.36	1.65	0.94	0.94
adipose tissue, adult, pool1	10010-101C1	34.59	33.97	21.25	3.88	1.86	0.78
adipose, donor1	10184-103D4	92.65	14.66	11.14	4.10	0.59	2.35
adipose, donor2	10185-103D5	33.25	8.92	2.43	3.65	0.00	0.41
adipose, donor3	10186-103D6	42.20	8.99	5.99	1.36	1.36	3.00
adipose, donor4	10187-103D7	20.80	11.27	7.80	5.20	1.73	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	22.88	40.40	16.10	7.58	2.84	0.63
adrenal gland, adult, pool1	10081-102A9	54.57	10.91	14.55	3.64	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	33.48	47.36	15.61	4.80	2.13	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	47.16	6.43	3.57	0.71	0.00	1.07
amniotic membrane cells, donor1	12235-129G3	18.78	37.56	16.69	3.48	1.39	0.46
amniotic membrane cells, donor2	12236-129G4	40.23	23.67	22.65	4.40	3.04	0.34
amniotic membrane cells, donor3	12237-129G5	8.54	36.53	20.92	5.30	2.95	0.29
amygdala - adult, donor10196	10167-103B5	65.22	32.02	7.11	0.00	2.37	0.00
amygdala, adult, donor10252	10151-102I7	43.39	36.70	19.47	3.85	1.01	0.00
amygdala, newborn, donor10223	10360-105E9	24.85	17.11	12.27	3.23	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	69.52	29.16	6.37	3.18	1.78	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	28.90	18.09	12.80	3.09	0.66	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	96.87	13.70	9.69	3.01	1.00	1.67
aorta, adult, pool1	10052-101G7	22.56	16.28	11.38	4.51	1.18	0.00
appendix, adult	10189-103D9	45.41	39.59	20.18	5.82	2.33	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	70.16	60.53	9.97	5.16	4.13	0.34
artery, adult	10190-103E1	31.25	21.74	10.87	1.36	2.72	2.72
astrocytoma cell line:TM-31	10425-106D2	95.32	45.20	14.49	5.22	3.19	2.75
b cell line:RPMI1788	10427-106D4	63.64	34.65	11.00	2.68	1.49	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	36.35	13.04	4.44	1.11	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	41.18	18.56	5.95	2.38	1.29	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	33.81	51.72	3.35	1.51	4.02	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	17.34	19.57	12.86	2.80	1.12	0.56
bladder, adult, pool1	10011-101C2	48.13	35.09	18.25	4.02	0.76	0.22
blood, adult, pool1	10053-101G8	17.72	24.36	13.29	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	46.24	23.98	4.28	3.43	0.00	1.71
bone marrow, adult	10192-103E3	46.56	39.14	16.20	2.70	1.35	1.35
brain, adult, donor1	10084-102B3	13.33	14.35	3.08	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	37.64	30.29	11.02	2.67	1.34	0.67
brain, fetal, pool1	10085-102B4	16.03	21.37	34.73	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	41.30	49.22	34.36	7.60	3.63	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	34.20	69.90	14.48	2.50	3.62	0.37
breast, adult, donor1	10080-102A8	23.36	14.52	10.73	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	11.05	18.80	3.05	1.02	1.14	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	42.98	31.54	4.33	2.16	0.93	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	40.06	11.51	4.14	1.38	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.01	48.18	6.05	3.87	1.94	0.24
carcinoid cell line:NCI-H1770	10703-109H1	14.58	40.43	4.70	4.70	1.88	0.00
carcinoid cell line:NCI-H727	10735-110B6	73.61	79.96	20.89	8.53	6.67	1.42
carcinoid cell line:SK-PN-DW	10719-109I8	10.14	24.72	23.13	2.85	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	57.23	24.75	16.24	2.13	1.33	2.93
caudate nucleus - adult, donor10196	10177-103C6	54.11	28.78	26.48	1.15	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	38.32	32.96	18.74	4.02	2.84	0.00
caudate nucleus, adult, donor10258	10379-105H1	29.80	32.86	12.99	2.29	3.06	0.76
caudate nucleus, newborn, donor10223	10354-105E3	21.61	18.68	15.02	2.93	2.56	0.00
cerebellum - adult, donor10196	10173-103C2	90.31	34.96	26.22	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	83.27	52.31	23.27	3.42	2.14	0.21
cerebellum, adult, pool1	10083-102B2	32.42	20.70	11.04	0.34	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	67.25	30.72	20.76	5.81	2.49	0.00
cerebral meninges, adult	10188-103D8	48.41	30.76	13.11	2.02	1.01	0.76
cerebrospinal fluid, donor2	10294-104G6	32.89	22.66	9.50	1.46	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	19.27	30.48	5.90	1.44	0.58	0.14
cervical cancer cell line:ME-180	10553-107I4	44.58	30.49	8.29	2.65	3.15	0.83
cervix, adult, pool1	10013-101C4	39.69	34.65	28.03	6.40	2.10	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	42.64	25.64	7.25	3.48	1.39	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	13.06	5.23	0.00	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	34.18	50.21	13.30	3.85	2.24	1.24
choriocarcinoma cell line:SCH	10785-110H2	14.17	26.49	6.90	1.85	1.85	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	7.83	28.94	7.12	1.42	1.90	0.00
chorionic membrane cells, donor1	12238-129G6	15.67	36.75	8.26	3.13	1.42	0.00
chorionic membrane cells, donor2	12239-129G7	60.55	21.18	6.07	0.89	0.20	0.50
chorionic membrane cells, donor3	12240-129G8	17.58	46.16	13.19	4.40	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	23.23	16.16	2.02	2.02	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	27.09	20.17	4.42	2.88	1.34	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	27.03	27.45	6.12	3.80	1.06	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	33.64	20.03	5.91	2.05	1.28	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	29.99	24.67	7.50	3.63	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	50.09	22.80	7.53	4.48	0.41	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	38.87	23.85	10.31	2.06	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	43.52	35.45	8.08	4.69	1.04	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	47.77	35.20	8.91	3.66	1.14	0.91
clear cell carcinoma cell line:TEN	10636-108I6	51.36	13.01	2.95	1.04	0.69	0.52
colon carcinoma cell line:CACO-2	10513-107D9	42.65	35.69	7.87	2.93	1.65	2.20
colon carcinoma cell line:COLO-320	10420-106C6	44.85	37.25	21.66	1.14	3.04	0.76
colon, adult, donor1	10082-102B1	13.09	9.52	8.33	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	36.78	46.18	17.16	4.23	2.82	0.12
colon, fetal, donor1	10070-101I7	31.52	33.99	11.74	5.56	3.09	0.00
common myeloid progenitor CMP, donor1	12130-128D6	119.17	238.34	105.42	36.67	22.92	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	152.13	4.67	2.12	1.70	0.42	13.17
cord blood derived cell line:COBL-a 24h infection	10453-106G3	84.37	2.41	2.57	0.60	0.60	5.74
cord blood derived cell line:COBL-a untreated	10449-106F8	88.56	5.78	2.68	0.71	0.14	4.09
corpus callosum, adult, pool1	10042-101F6	27.20	52.63	30.29	6.85	3.76	0.44
cruciate ligament, donor2	10295-104G7	51.06	34.04	12.97	2.43	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	25.68	16.05	14.45	4.01	1.61	0.80
diencephalon, adult	10193-103E4	23.76	43.20	18.96	3.12	3.36	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	28.01	19.06	8.04	2.07	0.92	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	36.41	48.72	5.39	5.13	2.31	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	51.03	23.59	6.02	0.96	0.48	0.48
ductus deferens, adult	10196-103E7	56.31	42.36	15.95	3.49	1.99	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	30.24	21.60	5.76	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	45.61	43.40	30.90	10.30	2.21	0.74
dura mater, adult, donor1	10041-101F5	59.22	45.42	17.10	3.06	1.16	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	67.73	8.88	5.55	2.00	1.78	3.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	42.41	12.47	11.32	2.72	1.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	48.71	21.58	4.32	1.23	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	39.05	7.27	1.21	0.30	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	50.94	14.82	2.47	2.47	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	66.99	24.96	1.31	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	55.64	14.75	2.35	1.68	0.34	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.75	17.22	4.89	0.91	0.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	30.39	19.78	9.17	3.06	0.32	0.64
epidermoid carcinoma cell line:A431	10426-106D3	40.57	22.45	5.67	2.45	1.11	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	44.98	28.60	5.28	2.86	1.76	0.77
epididymis, adult	10197-103E8	61.12	30.98	16.54	1.88	1.67	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	56.59	19.34	9.23	1.42	0.71	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	49.16	10.22	3.93	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	23.06	25.42	7.34	2.23	2.75	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	27.36	28.64	5.31	1.77	1.87	1.48
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	25.77	24.65	6.72	2.91	2.13	0.22
esophagus, adult, pool1	10015-101C6	24.63	29.62	19.11	2.23	1.81	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	104.70	20.41	15.15	2.25	0.50	0.63
eye - muscle inferior rectus, donor1	10272-104E2	65.19	41.05	2.41	4.83	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	48.40	35.77	18.94	8.42	0.00	0.00
eye - muscle medial, donor2	10299-104H2	102.69	32.74	20.84	4.46	1.49	0.00
eye - muscle superior, donor2	10297-104G9	48.15	27.52	18.34	8.03	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	56.84	40.81	7.29	2.91	1.46	0.00
eye, fetal, donor1	10054-101G9	45.25	31.02	21.36	8.39	2.29	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	20.13	11.16	1.92	1.67	0.38	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	26.83	15.67	7.36	2.37	1.42	0.00
frontal lobe, adult, pool1	10040-101F4	55.54	36.69	15.29	3.19	2.63	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	43.24	37.23	5.40	1.80	2.70	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	28.53	13.44	1.37	0.64	0.18	0.37
gall bladder, adult	10198-103E9	31.87	37.42	14.49	4.10	1.69	0.24
gamma delta positive T cells, donor1	11937-126A2	27.38	59.05	26.84	6.98	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	36.98	42.95	15.69	6.35	1.87	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	31.47	17.53	5.49	1.06	1.27	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	35.78	65.95	8.70	1.93	3.48	0.58
gastric cancer cell line:AZ521	10549-107H9	65.58	20.66	7.54	1.97	0.49	1.64
gastric cancer cell line:GSS	10560-108A2	19.22	50.34	14.64	2.75	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	35.18	55.97	19.19	7.77	3.66	0.23
giant cell carcinoma cell line:LU65	10487-107B1	11.59	18.59	4.02	0.92	1.03	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	75.02	24.07	7.56	0.98	1.26	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	39.91	39.41	5.99	3.24	2.24	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	74.84	24.07	9.18	3.38	1.16	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	80.33	25.28	9.83	3.65	1.54	1.12
glioblastoma cell line:T98G	10485-107A8	52.32	14.02	9.49	2.21	0.33	0.66
glioma cell line:GI-1	10413-106B8	35.73	10.25	6.74	1.76	0.29	1.17
globus pallidus - adult, donor10196	10175-103C4	32.80	50.29	20.41	1.46	4.37	0.00
globus pallidus, adult, donor10252	10161-103A8	38.32	63.95	37.35	7.32	6.83	0.24
globus pallidus, adult, donor10258	10367-105F7	15.06	46.55	26.01	5.48	8.22	0.00
globus pallidus, newborn, donor10223	10364-105F4	15.45	26.11	9.59	5.33	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	80.76	278.97	68.52	26.92	12.24	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	65.57	32.79	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	20.91	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	51.84	13.44	2.88	0.32	0.64	0.64
hIPS +CCl2, biol_rep1	14383-156B9	26.63	24.33	9.18	1.84	1.38	0.46
hIPS +CCl2, biol_rep2	14384-156C1	25.61	19.66	10.06	3.20	0.91	0.91
hIPS +CCl2, biol_rep3	14385-156C2	26.41	15.46	15.46	5.15	1.93	0.00
hIPS, biol_rep1	14380-156B6	21.56	14.37	11.50	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	19.89	21.95	14.40	1.37	2.06	0.69
hIPS, biol_rep3	14382-156B8	26.48	35.31	27.59	0.00	4.41	0.00
hairy cell leukemia cell line:Mo	10712-109I1	58.91	10.63	2.87	0.57	0.00	1.44
heart - mitral valve, adult	10205-103F7	38.27	27.21	17.94	5.08	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	37.39	32.16	14.38	3.92	2.09	0.00
heart - tricuspid valve, adult	10207-103F9	63.28	25.81	24.98	5.00	2.50	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	22.04	13.06	7.14	0.41	0.41	0.82
heart, adult, diseased, donor1	10051-101G6	9.79	8.94	9.79	1.28	0.43	0.43
heart, adult, pool1	10016-101C7	25.07	28.06	21.39	3.45	1.38	0.69
heart, fetal, pool1	10046-101G1	51.13	36.96	28.03	5.85	2.46	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	45.66	10.80	4.32	0.93	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	64.22	42.81	14.27	5.95	3.57	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	82.87	29.94	6.96	2.10	1.55	2.54
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	99.16	36.17	8.62	2.43	0.97	3.40
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	101.05	38.40	10.21	3.94	1.92	4.65
hepatoma cell line:Li-7	10484-107A7	66.06	21.24	5.67	1.00	1.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	30.45	20.30	5.73	1.71	1.31	0.60
hippocampus - adult, donor10196	10169-103B7	63.40	34.07	20.82	2.84	2.84	0.95
hippocampus, adult, donor10252	10153-102I9	38.57	40.82	26.33	7.96	2.25	0.00
hippocampus, adult, donor10258	10374-105G5	47.80	29.88	11.45	2.49	1.49	1.49
hippocampus, newborn, donor10223	10363-105F3	25.73	15.86	8.81	1.76	1.41	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	17.70	24.41	25.02	7.32	2.44	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	18.06	16.49	14.53	5.89	2.16	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	13.46	18.79	18.79	6.86	1.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	26.50	12.41	7.33	3.95	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	33.31	11.88	8.26	2.84	1.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	37.58	10.25	10.63	4.56	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	50.51	14.01	7.30	2.63	0.58	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	44.81	13.14	7.32	2.37	1.51	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	51.30	16.27	6.26	4.17	2.09	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	52.80	17.76	8.05	3.55	0.47	2.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	37.29	12.21	9.00	1.77	0.96	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	34.34	20.87	6.06	0.00	0.67	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.02	14.40	12.21	2.50	2.35	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	13.76	13.76	13.26	4.42	2.46	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	24.44	13.96	18.33	3.49	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	50.21	11.84	7.83	3.05	1.15	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	49.71	16.13	6.11	4.36	0.87	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	52.47	14.49	10.99	3.50	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	32.78	14.13	9.04	3.58	1.13	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	37.74	20.01	9.09	5.46	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	36.65	13.78	7.52	0.94	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	46.87	13.06	4.08	2.29	0.82	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	42.09	10.45	6.10	2.61	1.45	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	39.16	10.16	4.18	1.79	0.60	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	22.35	12.75	13.49	4.99	1.48	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	19.11	13.12	11.13	2.57	1.71	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	28.17	24.50	15.52	5.72	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	47.53	14.08	9.15	2.82	3.17	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	32.31	14.25	5.70	1.90	1.27	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	38.74	14.22	5.45	3.63	1.82	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	49.64	15.51	4.65	2.07	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	53.80	17.27	8.63	3.32	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	43.10	15.14	7.70	2.05	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	50.36	14.06	5.11	1.53	0.51	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	81.02	21.20	5.30	1.51	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	44.36	13.78	1.68	2.69	0.67	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	25.12	15.21	12.08	2.42	0.48	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.50	21.39	13.37	4.01	2.23	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	15.61	14.63	4.88	3.41	2.44	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	51.65	11.61	11.00	4.28	1.53	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	247.25	71.57	35.79	19.52	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	55.27	17.54	9.27	5.30	0.66	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	43.78	17.51	7.66	3.83	1.64	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	37.64	20.99	6.51	3.62	0.72	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	41.28	10.68	4.98	2.14	1.78	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	35.80	14.32	2.39	0.00	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	61.62	20.04	6.50	3.25	2.17	1.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	35.02	9.70	5.12	1.35	0.27	1.89
immature langerhans cells, donor1	11904-125F5	47.46	57.39	8.72	2.66	2.66	0.48
immature langerhans cells, donor2	11905-125F6	26.93	41.98	19.01	5.54	4.75	0.79
insula, adult, pool1	10039-101F3	48.26	27.07	10.88	2.74	2.27	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	16.58	23.74	5.53	2.93	0.98	0.65
kidney, adult, pool1	10017-101C8	46.36	41.55	19.52	3.40	2.10	0.30
kidney, fetal, pool1	10045-101F9	21.50	21.93	27.73	3.54	1.56	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	59.51	31.10	5.25	2.98	1.85	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	27.37	18.11	4.29	0.41	0.55	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	52.48	21.65	8.44	2.20	1.83	0.55
left atrium, adult, donor1	10079-102A7	22.88	11.99	3.81	1.09	1.09	0.00
left ventricle, adult, donor1	10078-102A6	18.71	18.71	4.55	1.52	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	56.36	15.60	9.85	1.64	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	17.96	8.98	1.80	0.36	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	21.20	5.43	2.72	0.54	0.54	1.09
leiomyoma cell line:15425	10571-108B4	20.88	13.35	3.89	0.97	0.73	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	12.70	0.00	0.00	6.35	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	50.19	6.27	3.14	0.00	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	28.92	31.76	8.97	5.78	1.89	0.59
liposarcoma cell line:KMLS-1	10782-110G8	63.73	17.03	2.66	1.87	1.09	0.78
liposarcoma cell line:SW 872	10726-110A6	34.72	16.69	3.29	1.58	0.85	1.10
liver, adult, pool1	10018-101C9	68.23	58.34	22.69	4.70	5.35	1.46
liver, fetal, pool1	10086-102B5	15.99	17.87	12.23	1.88	2.82	0.94
locus coeruleus - adult, donor10196	10182-103D2	38.35	41.41	18.81	4.67	3.65	0.29
locus coeruleus, adult, donor10252	10165-103B3	34.70	41.89	20.12	4.98	1.11	0.37
locus coeruleus, adult, donor10258	10375-105G6	24.55	21.44	15.80	2.54	2.54	0.28
locus coeruleus, newborn, donor10223	10362-105F2	21.87	18.09	15.98	5.47	4.21	0.84
lung adenocarcinoma cell line:A549	10499-107C4	41.93	30.45	6.23	1.11	0.97	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	53.08	47.57	15.17	5.52	2.07	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	44.82	38.09	8.44	5.27	1.45	0.53
lung, adult, pool1	10019-101D1	40.99	41.11	20.08	5.43	1.18	0.00
lung, fetal, donor1	10068-101I5	88.19	78.20	70.50	17.41	4.85	0.57
lung, right lower lobe, adult, donor1	10075-102A3	30.24	21.99	11.46	4.58	1.83	0.00
lymph node, adult, donor1	10077-102A5	23.19	16.09	7.10	1.89	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	23.89	30.47	7.45	3.07	1.10	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	24.90	19.47	2.72	1.96	0.75	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	42.47	32.28	11.89	6.80	1.70	0.00
mature adipocyte, donor1	12231-129F8	32.41	47.95	17.32	3.55	2.22	0.44
mature adipocyte, donor2	12232-129F9	40.47	42.96	16.39	3.11	2.28	1.25
mature adipocyte, donor3	12233-129G1	31.29	39.83	10.90	4.27	1.19	0.71
mature adipocyte, donor4	12234-129G2	32.11	41.06	24.22	3.95	2.11	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	64.81	105.31	25.26	7.62	6.91	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	71.07	18.05	7.90	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	45.06	25.75	21.33	4.05	1.47	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	38.76	13.34	6.67	1.91	1.27	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	52.46	17.06	10.66	2.13	1.28	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	61.59	24.98	10.80	3.04	1.69	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	43.93	43.72	20.37	4.67	1.06	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	57.79	25.04	5.78	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	373.19	143.54	28.71	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	35.18	14.72	12.20	2.51	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	63.60	36.99	21.42	4.54	1.95	0.65
medulla oblongata, adult, donor10252	10155-103A2	43.35	41.33	25.70	6.04	2.94	0.15
medulla oblongata, adult, pool1	10038-101F2	22.37	32.24	20.08	3.10	1.96	0.57
medulla oblongata, newborn, donor10223	10361-105F1	19.09	21.87	17.36	5.90	1.74	1.04
medulloblastoma cell line:D283 Med	10838-111E1	43.18	48.93	29.89	10.18	7.75	0.22
medulloblastoma cell line:ONS-76	10759-110E3	22.99	12.72	4.04	2.20	0.49	0.37
melanoma cell line:COLO 679	10514-107E1	25.87	8.05	5.32	1.44	1.01	0.43
melanoma cell line:G-361	10465-106H6	38.55	11.13	1.63	0.27	0.27	0.54
meningioma cell line:HKBMM	10691-109F7	34.37	10.49	1.99	1.09	1.09	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	56.39	59.92	21.15	3.52	3.52	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	48.47	55.21	18.92	7.00	4.15	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	41.12	9.36	5.52	1.69	0.15	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	52.35	9.82	2.36	1.09	0.00	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	41.00	7.45	5.80	1.24	1.24	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	45.37	11.52	4.50	0.70	0.28	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	45.25	7.90	3.27	0.19	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	30.54	14.58	5.55	2.08	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	28.32	18.36	4.81	1.20	0.69	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	40.37	9.32	3.68	0.69	0.58	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	35.81	10.35	3.18	0.93	0.53	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	50.78	13.50	4.73	0.95	0.27	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	63.59	13.80	5.12	1.56	0.71	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	43.80	15.81	6.59	1.65	0.33	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	61.02	10.24	2.21	1.52	0.55	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	43.64	7.68	5.59	0.70	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	53.08	8.57	2.65	0.20	0.00	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	28.76	8.27	2.88	1.44	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	38.48	9.21	3.83	0.62	0.21	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	21.43	10.03	4.33	1.82	0.46	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	71.32	21.40	9.23	3.36	0.42	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	51.85	12.55	3.44	1.05	0.60	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	52.96	14.44	4.38	0.96	0.88	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	45.65	5.89	3.68	0.37	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	46.64	9.16	3.72	0.86	0.57	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.84	19.37	7.16	1.68	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	17.81	12.79	5.02	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	19.44	14.32	5.37	0.77	1.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.99	15.18	7.85	1.57	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.71	14.17	8.93	0.62	0.92	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.95	14.12	6.83	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	18.28	12.18	5.75	1.69	1.02	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	19.65	13.75	6.29	1.18	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.54	13.90	5.56	0.93	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.98	18.17	8.08	1.73	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	19.63	14.72	6.69	2.45	1.34	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.55	13.70	7.69	0.96	1.68	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	23.47	19.07	8.80	4.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	17.79	10.07	5.37	2.35	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	18.42	15.56	3.68	0.00	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	20.62	16.75	6.44	0.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	10.94	8.20	2.73	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	10.33	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.81	11.04	5.85	1.30	1.62	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	14.55	5.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.19	10.13	2.67	0.53	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	10.63	5.72	2.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.55	14.38	5.44	1.17	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	25.18	14.69	8.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	6.95	5.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	9.53	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.13	11.86	6.52	0.59	1.19	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	13.40	6.09	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.93	11.40	3.80	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.35	10.69	3.45	1.72	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	17.19	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	10.33	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	16.30	10.59	2.44	1.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.83	8.74	0.79	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.63	6.48	2.95	1.77	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.03	11.53	3.12	0.62	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	5.35	6.68	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	8.28	4.73	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	7.70	5.14	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	31.67	5.51	2.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	15.34	12.86	8.91	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	6.73	2.24	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	18.45	11.45	4.45	0.64	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.48	10.07	7.25	0.81	1.21	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	6.54	6.54	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	6.34	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.17	18.81	4.86	1.21	3.03	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	0.00	9.04	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	16.47	12.36	5.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.82	11.51	5.95	0.00	0.79	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	18.17	8.44	3.57	0.97	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	24.45	11.20	5.09	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	29.40	28.63	12.38	3.87	1.55	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	58.12	33.55	8.03	1.18	0.94	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	99.16	13.67	5.10	2.55	0.93	2.09
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	40.38	7.81	2.26	0.92	0.21	0.62
mesothelioma cell line:Mero-25	10850-111F4	26.78	9.99	1.36	0.45	1.13	0.45
mesothelioma cell line:Mero-41	10851-111F5	49.63	20.05	3.67	0.98	1.47	0.00
mesothelioma cell line:Mero-48a	10852-111F6	28.79	12.18	4.43	1.33	1.99	0.00
mesothelioma cell line:Mero-82	10853-111F7	47.83	13.67	2.37	0.79	0.79	2.37
mesothelioma cell line:Mero-83	10854-111F8	38.81	10.21	1.87	0.51	0.34	0.68
mesothelioma cell line:Mero-84	10855-111F9	6.82	4.80	28.82	3.03	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	30.85	13.87	4.76	0.83	1.24	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	38.43	12.09	3.15	1.82	0.66	0.83
mesothelioma cell line:NCI-H226	10846-111E9	43.80	5.97	1.81	1.27	0.00	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	59.79	21.35	4.78	2.22	0.51	0.51
mesothelioma cell line:NCI-H28	10845-111E8	38.17	27.74	16.54	2.29	2.04	0.51
mesothelioma cell line:No36	10857-111G2	15.33	8.16	3.26	2.28	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	54.46	8.13	1.35	1.90	1.08	1.35
migratory langerhans cells, donor1	11901-125F2	53.74	25.91	13.05	1.92	1.34	1.34
migratory langerhans cells, donor2	11902-125F3	37.37	23.08	10.87	1.47	1.10	0.37
migratory langerhans cells, donor3	11903-125F4	53.13	33.74	10.05	1.62	1.44	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	30.69	12.08	3.92	0.33	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	17.59	8.90	1.06	0.85	0.21	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	39.62	36.63	7.14	5.07	2.30	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	49.29	9.13	4.57	0.95	0.57	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	28.83	36.40	4.99	2.22	0.74	0.37
myeloma cell line:PCM6	10474-106I6	46.25	39.93	7.91	1.78	0.99	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	44.64	23.84	4.06	2.54	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	41.39	23.14	7.85	2.55	0.98	1.57
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.92	24.51	5.57	1.67	0.56	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.28	19.86	5.00	1.62	0.59	0.07
nasal epithelial cells, donor2	12227-129F4	29.26	18.22	2.76	1.66	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	86.04	64.65	14.49	10.12	5.98	1.61
neuroblastoma cell line:NB-1	10539-107G8	54.44	34.05	26.00	6.17	2.43	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	33.74	31.00	6.12	3.37	1.27	0.84
neuroblastoma cell line:NH-12	10555-107I6	30.56	37.27	19.75	5.59	2.61	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	9.96	31.08	23.49	5.69	1.19	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	17.26	26.77	27.72	4.12	2.53	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	25.36	30.39	11.07	1.61	1.01	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	9.54	34.97	18.44	5.72	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	38.33	10.91	4.79	2.66	0.53	0.00
neutrophil PMN, donor1	12133-128D9	252.87	357.00	223.12	29.75	59.50	0.00
neutrophil PMN, donor2	12137-128E4	26.56	26.56	13.28	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	28.41	85.24	18.94	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	178.76	93.52	24.35	11.50	5.41	2.37
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	56.84	41.63	14.41	5.60	1.60	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	38.15	11.54	7.37	2.56	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	47.56	14.45	3.94	1.84	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	43.68	38.06	15.94	3.09	1.78	0.19
occipital cortex - adult, donor10196	10172-103C1	70.05	39.15	16.48	4.12	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	48.31	40.25	25.76	4.56	2.42	0.27
occipital cortex, newborn, donor10223	10355-105E4	33.85	14.56	14.56	1.46	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	40.41	24.67	9.45	1.84	1.84	0.26
occipital lobe, fetal, donor1	10073-102A1	18.02	35.62	35.19	7.29	2.57	0.43
occipital pole, adult, pool1	10036-101E9	18.21	13.01	8.12	1.10	1.34	0.00
olfactory region, adult	10195-103E6	42.41	32.48	15.48	4.01	1.91	0.19
optic nerve, donor1	10277-104E7	46.02	84.04	34.02	10.01	8.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	36.45	31.89	10.71	3.42	2.39	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	102.49	64.43	13.05	6.18	2.06	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	24.38	15.58	7.28	1.02	0.68	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	41.47	12.71	2.66	0.92	0.58	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	30.28	8.53	5.59	1.76	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	85.96	43.91	3.74	3.74	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	24.81	23.75	16.96	5.51	2.54	0.64
ovary, adult, pool1	10020-101D2	45.95	26.38	26.82	6.03	2.18	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	38.68	18.88	10.27	3.12	1.65	0.00
pancreas, adult, donor1	10049-101G4	43.27	27.28	15.99	4.70	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	19.57	32.71	9.50	2.80	3.07	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	35.60	14.48	2.56	1.19	1.53	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	78.49	26.49	11.59	3.97	0.66	0.33
paracentral gyrus, adult, pool1	10035-101E8	43.47	30.39	12.63	2.38	2.11	0.37
parietal cortex, adult, donor10258	10373-105G4	41.84	25.69	14.68	5.87	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	49.85	31.04	15.99	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	47.60	35.34	14.25	3.99	2.00	0.00
parietal lobe, adult, pool1	10034-101E7	36.48	24.41	12.42	2.38	2.29	0.44
parietal lobe, fetal, donor1	10072-101I9	36.85	31.03	26.19	8.73	5.82	0.00
parietal lobe, newborn, donor10223	10356-105E5	34.02	8.97	11.22	2.62	2.24	0.75
parotid gland, adult	10199-103F1	44.40	59.20	12.95	6.17	1.85	0.62
penis, adult	10200-103F2	33.30	26.86	16.11	6.45	2.69	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	3.72	17.48	61.54	5.39	0.74	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	35.84	24.62	10.93	1.60	1.31	0.58
pineal gland - adult, donor10196	10179-103C8	118.04	32.25	12.26	4.52	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	122.00	54.48	16.58	6.51	2.37	1.78
pineal gland, adult, donor10258	10377-105G8	71.49	26.34	13.17	1.88	1.25	1.88
pituitary gland - adult, donor10196	10180-103C9	115.35	56.66	25.30	4.05	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	121.96	60.98	58.37	7.82	4.69	4.17
pituitary gland, adult, donor10258	10378-105G9	68.10	39.16	22.98	1.70	0.00	1.70
placenta, adult, pool1	10021-101D3	30.75	36.01	26.34	5.16	1.72	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	52.04	25.29	8.48	1.72	0.53	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	87.62	26.15	17.90	5.60	0.47	2.02
pons, adult, pool1	10033-101E6	44.07	49.23	15.49	4.39	3.44	0.60
postcentral gyrus, adult, pool1	10032-101E5	28.68	17.44	8.11	2.44	1.22	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	144.31	273.97	54.38	31.37	12.55	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	22.03	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	46.94	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	41.66	15.59	3.06	0.87	0.73	0.87
prostate cancer cell line:PC-3	10439-106E7	54.45	28.31	7.99	1.82	1.27	1.09
prostate, adult, pool1	10022-101D4	38.54	30.93	22.31	5.17	3.26	0.18
putamen, adult, donor10196	10176-103C5	58.31	33.76	13.46	4.01	1.89	0.00
putamen, adult, donor10252	10152-102I8	47.06	31.37	31.37	0.00	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	25.13	20.76	9.84	0.00	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	24.89	32.62	9.91	2.17	1.69	0.24
putamen, newborn, donor10223	10365-105F5	23.99	9.00	10.50	3.75	3.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	45.68	43.93	13.09	3.78	2.33	1.16
rectum, fetal, donor1	10067-101I4	57.03	27.82	30.60	5.56	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	40.07	27.35	11.87	3.39	0.85	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	51.36	31.07	5.80	3.31	0.83	0.00
retina, adult, pool1	10030-101E3	35.19	26.34	24.95	5.67	2.19	1.29
retinoblastoma cell line:Y79	10475-106I7	91.45	32.74	14.03	2.86	3.12	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	38.85	20.41	4.67	1.60	0.37	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	86.61	43.59	13.22	3.94	2.53	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	58.35	21.98	9.09	3.79	0.76	1.52
salivary acinar cells, donor1	11771-123I7	37.39	17.80	3.40	0.49	0.49	0.49
salivary acinar cells, donor2	11772-123I8	34.01	22.72	5.37	2.34	1.38	0.55
salivary acinar cells, donor3	11773-123I9	56.94	60.91	13.24	3.97	3.31	0.66
salivary gland, adult, pool1	10093-102C3	30.89	34.32	14.87	4.58	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	39.63	18.55	3.37	0.93	0.84	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	43.49	18.81	2.94	0.59	0.35	0.59
seminal vesicle, adult	10201-103F3	46.03	48.67	26.98	4.76	4.23	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	55.39	20.41	15.55	5.10	2.92	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	32.46	10.32	6.79	1.01	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	34.12	18.06	6.02	2.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	64.88	27.27	7.92	2.28	1.75	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	36.92	25.86	3.87	1.11	1.33	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	60.51	34.06	10.71	2.58	1.29	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	66.68	41.14	6.38	2.13	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	58.89	38.74	15.23	3.12	2.40	0.84
skeletal muscle, fetal, donor1	10066-101I3	11.06	10.05	11.06	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	33.93	20.36	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	37.87	32.19	26.51	6.94	2.52	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	29.35	31.68	17.68	5.00	3.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	101.50	40.35	21.75	9.14	3.15	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	15.61	20.43	10.22	1.93	0.58	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	76.31	67.91	16.32	6.59	7.09	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	28.63	32.49	32.81	7.56	3.54	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	66.03	34.65	5.01	1.31	1.96	2.18
small intestine, adult, pool1	10024-101D6	32.61	59.60	33.09	6.09	5.37	0.24
small intestine, fetal, donor1	10064-101I1	42.01	29.97	22.36	4.42	2.21	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	43.08	64.63	18.98	8.21	3.08	0.51
smooth muscle, adult, pool1	10048-101G3	28.43	21.71	20.42	1.81	1.29	0.00
somatostatinoma cell line:QGP-1	10781-110G7	89.52	105.06	10.72	9.11	5.36	0.54
spinal cord - adult, donor10196	10181-103D1	34.18	39.92	20.65	4.82	2.06	0.00
spinal cord, adult, donor10252	10159-103A6	39.03	49.68	31.54	6.70	2.76	0.00
spinal cord, adult, donor10258	10369-105F9	21.45	56.04	28.36	2.77	4.84	0.00
spinal cord, fetal, donor1	10056-101H2	33.54	32.93	21.95	1.22	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	26.63	39.03	28.47	4.13	3.67	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	37.64	16.28	4.03	2.54	1.05	0.60
spleen, adult, pool1	10025-101D7	42.95	22.69	10.13	2.20	1.10	0.33
spleen, fetal, pool1	10044-101F8	24.87	17.48	17.64	2.86	0.40	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	33.23	33.12	12.42	2.59	1.35	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	77.28	51.27	8.92	7.41	2.09	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	38.79	22.71	10.83	1.40	0.35	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	38.70	24.24	7.82	3.52	1.56	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	120.78	133.83	15.42	8.44	8.55	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.76	31.35	9.74	3.39	1.69	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	64.31	33.85	7.19	0.85	1.69	0.42
stomach, fetal, donor1	10062-101H8	63.01	51.26	22.43	3.20	3.20	1.07
submaxillary gland, adult	10202-103F4	51.84	49.56	19.94	2.85	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	35.10	53.80	22.43	6.65	3.12	0.62
substantia nigra, adult, donor10258	10371-105G2	32.07	33.62	17.59	4.14	3.62	0.00
substantia nigra, newborn, donor10223	10358-105E7	26.14	17.66	21.20	4.24	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	32.78	25.91	8.02	3.21	0.69	0.23
temporal lobe, adult, pool1	10031-101E4	21.96	13.48	7.80	1.78	0.68	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	18.52	30.63	24.22	4.99	2.14	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	17.58	21.54	30.33	3.96	1.32	0.00
tenocyte, donor1	11763-123H8	43.29	19.55	8.38	2.44	0.35	0.70
tenocyte, donor2	11765-123I1	43.11	13.73	14.50	1.91	0.00	1.53
tenocyte, donor3	11768-123I4	40.03	18.53	4.82	1.11	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	35.01	19.72	19.38	4.93	2.04	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	23.28	13.41	9.71	1.54	1.23	0.31
teratocarcinoma cell line:PA-1	10807-111A6	18.60	11.78	8.06	2.32	1.08	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.83	31.10	23.74	7.24	2.41	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	46.52	48.41	36.68	9.83	3.03	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	27.70	40.68	26.72	8.83	3.71	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	12.70	15.96	22.80	11.07	2.61	0.33
testis, adult, pool1	10026-101D8	54.01	62.71	19.65	3.65	2.36	0.86
testis, adult, pool2	10096-102C6	37.89	69.02	19.85	7.67	5.41	0.90
thalamus - adult, donor10196	10168-103B6	47.47	48.58	36.43	6.62	8.83	0.00
thalamus, adult, donor10252	10154-103A1	36.88	50.17	30.79	7.50	3.13	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	44.65	38.49	21.55	4.62	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	17.13	15.32	9.55	1.32	1.15	0.16
thalamus, newborn, donor10223	10366-105F6	36.82	7.48	11.51	1.15	1.73	0.00
throat, adult	10209-103G2	31.46	31.21	14.98	3.99	2.00	0.50
throat, fetal, donor1	10061-101H7	39.92	28.34	20.11	4.88	2.74	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	17.49	31.00	25.04	7.75	1.79	0.20
thymus, adult, pool1	10027-101D9	22.37	49.21	74.06	13.52	3.58	0.50
thymus, fetal, pool1	10043-101F7	40.21	65.25	85.10	15.17	4.99	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	36.03	14.49	3.19	1.99	0.93	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	27.80	19.98	3.91	1.68	1.12	0.70
thyroid, adult, pool1	10028-101E1	54.21	46.19	34.06	4.76	2.61	1.40
thyroid, fetal, donor1	10060-101H6	46.40	37.44	27.68	7.65	2.11	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	61.59	15.40	3.08	3.08	3.08
tongue, adult	10203-103F5	22.79	31.86	11.40	3.26	1.86	0.47
tongue, fetal, donor1	10059-101H5	29.56	24.83	19.31	3.55	1.97	0.79
tonsil, adult, pool1	10047-101G2	31.76	35.56	16.93	3.41	1.70	0.60
trachea, adult, pool1	10029-101E2	50.47	39.43	20.04	4.83	2.21	0.33
trachea, fetal, donor1	10058-101H4	50.39	26.16	25.01	6.92	1.15	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	35.43	10.27	3.54	1.42	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	51.27	22.29	3.14	1.93	0.91	1.52
transitional-cell carcinoma cell line:JMSU1	10492-107B6	61.89	47.79	8.77	3.92	3.13	1.25
tridermal teratoma cell line:HGRT	10694-109G1	72.30	30.44	9.51	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	45.20	23.02	8.89	2.54	1.52	0.25
umbilical cord, fetal, donor1	10057-101H3	29.21	16.69	14.61	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	39.42	28.67	29.69	6.31	3.07	0.17
uterus, fetal, donor1	10055-101H1	57.34	30.72	18.94	6.66	0.51	0.51
vagina, adult	10204-103F6	23.91	34.89	36.83	5.82	1.29	0.00
vein, adult	10191-103E2	28.06	29.15	19.07	4.38	1.53	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	37.92	14.69	2.40	0.53	0.27	0.80

Property "Nearest transcripts" (as page type) with input value "BC035594:41 ENST00000426921.5:52 EF199840:68 AK311058:-92 BX647662:94 ENST00000272638.14:121 NM_014607.4:121 AK304096:121 BX647216:127 D87684:132 ENST00000416538.5:134 BC020806:134 AK292829:192 KJ902297:196 CU690126:196 AB527369:196 AM392761:196 AM393478:196 DQ894302:196 KJ893338:196 DQ891123:196 AK026971:262" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.